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for the Degree of uoctor of ~hilo~ophy 
A study was made of the fixation of complement by anti gens 
of foot-and-mouth disease virus ( FMDV). The technique was 
applied to the determination of the serological properties of 
FMDV anti g ens and to the differentiation and classification 
of strains. 
An examination was made of the relationships between 
an t i gen, antibody and the fixation of complement. Complement 
fixation ( C F) with FMDV followed the same principles as models 
developed in other anti gen/ antibody sy stems ■ The assumption 
that there is a relationship of direct proportionality between 
the amount of complement fixed and the amount of antiserum 
reactine with constant anti ~en, was found to be incorrect. An 
alternative method was proposed for the quantitative differ-
entiation of FMN str6.im11. 
Applying this method, isolat e d FMDV antigens were examined 
for type and sub-typ e specificity. The intact virion was type 
s pecific and possessed considerable eub-type specificity. In 
c ontrast, capsid sub-units reacted heterotypically and with less 
sub-type specificity ■ A non-structural virus infection-associlt4!d 
anti ~en had virtually no t ype or sub-type specificity. b mpty 
capsids were shown to possess the same sub-type specificity as 
intact virions, while trypsin-treated virus was more cross-
reactive. ~he implications of the serological activity of these 
anti gens were discussed, in relation to the structure of the 
virion and to the application of CF to routine typing and sub-
typin~ procedures. 
The CF teat wae compared to croae-protection and cross-
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neutralisation tests for the determination of differen~es between 
strains and found to produce similar results. A large number 
of strains of one type were compared in croes-C~ tests and from 
the results it was shown that the present methods of sub-type 
classification are unsatisfactory. A new system for the sub-type 
classification of FHDV strains was proposed. 
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GJ;:;NEHAL IN'rRODUCTION 
Foot-and-mouth disease (FMD) is an acute and highly 
contagious infection of ruminants and swine. It is charact-
erised by the development of vesicles, particularly in the 
oral cavity and the interdigital and coronary skin. While it 
is generally not a killing disease except in young animals, 
the acute stage of the disease is often followed by a prolonged 
period or convalescence ~hich results in a marked loss of 
production of meat and milk and of reproductive performance. 
The disease is endemic throughout most of Europe, Asia, 
Africa and South America and has made incursions into most 
other parts of the world. It has never occurred in New 
~ealand and probably only once in Australia in 1872 (Seddon, 
1966). It last occurred in the United States in 1929, in 
Canada in 1952 and in Mexico in 1953 (Callis~•• 1968). 
Britain maintains an uneasy freedom, having suffered ite 
ravages almost anually to 1968 when the last epidemic was 
halted. Control of the disease during the 1967-68 epidemic 
resulted in the slaughter of more than ~00,000 iivestock at a 
direct coat of over £35 million (Ministry of Agriculture, 1968). 
FMD is tolerated only at the cost of inefficient liveatock 
production. It is controlled by expenaive vaccination achemea 
and by the regulation of liveatook movement. Freedom is main-
tained only by etringent quarantine regulatione. 'l'hus no 
oountry ie unaffected by the di••••• which remains one of the 
most economically important di•••••• of liveatook. 
FMD was the first animal disease demonetrated to be or 
viral aetiology when in 1897, Loeffler and Froaoh ahowed that 
the causative a gent passed tnrough bacterial filters. Foot-
and-mouth disease virus (FMDV) was later shown to poaaesa 
certain characteristics which enabled the International 
Committee ~r Nomenclature of Viruses to classify it in the 
Picornaviridae family C•ildy, 1971). The members are small 
(20-30 nm.), isometric (probably icosanedral), naked vertebrate 
viruses, ether-resistant and containing single-stranded RNA. 
The Committee further classified YMUV into the genus Rhinovirus, 
mainly on the basis or its instability at pH3. However, Newman 
~• (1973) have questioned the validity of this grouping and 
have suggested an alternative classification of picornavirusea 
into six sub-groups on the basis of bouyant density in caesium 
chloride, stability over the range of pH3 to 7 and the base 
composition of the RNA genome. Their system places FHDV in a 
sub-group with equine rhinoviruaea but not with human rhino-
viruses. 
FMDV was the first virus shown to poaaeea immunological 
variability when in 1922, Vall~• and Carr~ demonstrated on the 
basis of cross-immunity teats, two distinct types, 0 and A. 
Maldmann and Trautwein (1926) distinguished a further type, C, 
and three others were isolated from Southern African Territories; 
types SAT 1 1 dAT 2, and SAT 3 (Brookaby 1 1958). Finally, a 
seventh type, Asia 1 1 was discovered in 1954 (Brookaby and 
Rogers, 1957). 
•hile the seven FHUV types are immunologically quite 
diatinct, within each type there i• a range of antigenic 
variation between strains. Such variation was first demon-
strated by waldmann and Trautwein (1926) by cross-immunity 
teats and by Bedson~• (1927) in cross aervm neutralisation 
tests. Strains within a type have been classified into groups 
designated as sub-types. The significance of such classification 
is primarily in relation to the protection of immunised animals 
against field challenge with a different strain. 
In 1946, Traub and M~hlmann first applied complement-
fixation (CF) to the differentiation of intra-type strains and 
since then, this method has become univeraally popular for the 
identification of sub-types. However, many other immunological 
methods have also been used. 
Cross serum neutralisation tests have been used by various 
workers (Brooksby ~•• 1948 b; Hyslop~•• 1~63; Hedger 
and Herniman, 1966) to demonstrate antigenic differences 
between strains. However the methods used have generally 
given poor reproducibility and have not found wide application. 
An agar gel precipitation teat has been deacribed by 
Graves (1960) for FMDV sub-type differentiation. However, 
difficulties of accurate measurement of the reactions preclude 
the technique from uae for quantitative studies. The radial 
immunodiffuaion teat of Mancini.!!..-!!• (1964; 1965) haa a 
greater potential but has not been used for the differentiation 
of FMDV strains. It has however, been applied by Cowan and 
Wagner (1970) for detection and measurement of FHDV antibodies 
with considerable success although it was found to have 
limitations, in that reversed diffusion (antiserum placed in 
the well• and antigen incorporated into the gel) was leaa 
satisfactory tor the accurate measurement of antibody levela. 
~ther methods which have been applied include a paaaive 
haemagglutination inhibition teat (Warrington and Kawakami, 1972) 
and a passive immuno-haemolysis test (Wittmann and Reda, 1972). 
Both of these methods were used to demonstrate sub-type 
differences and were reproducible, but have not been applied 
extensively. 
The CF test is one of the most universally applied methods 
for the detection and quantification of serological reactions. 
The methods used in most situations are based on standard 
techniques (see for example Casey, 1965) which are valid in 
terms of the criteria determined by earlier workers for the 
quantitative estimation of the fixation of complement. 
However the method which has been used in the Norld 
Reference Laboratory for FKD at this lnstitute, and elsewhere, 
for the demonstration of sub-type differences with FMDV is 
unique and differs in the assumptions on which it is based. 
The only experimental justification for the method (Bradish 
~•• 1~b0 a) is open to interpretation and is contradictory 
to the criteria determined with other complement-fixing systems. 
The first Section of this thesis describes experiments 
carried out to investigate the relationships between antigen, 
antibody and the fixation of complement in the FMDV system. 
~vidence is presented suggesting that the basis of the method 
described by Bradish~• (19bO a) is invalid and a different 
approach is proposed for the differentiation of FHDV strains 
by CF. 
Considerable knowledge of the structure of FMDV has been 
gained from biochemical, biophysical and serological studies 
with the virus. However, in the main, serolo~ical investigations 
of anti~enic components of FMDV have been approached from a 
qualitative point of view and there is very little quantitative 
,, 
information regarding the type and sub-type specificities of 
viral components. It has been demonstrated that the anti genic 
activity of intact virus particles ia type specific (Brown and 
Crick, 1958) but cross-reactive between sub-types (Bradish and 
Brooksby, 1960). However, cross-reactions between types occur 
with 12S particles (Brown and Crick, 19581 Bradish and Brooksby, 
1960), which are the structural sub-units of the viral capsid. 
A non-structural viral anti gen, identified by Cowan and Graves 
(1966) (virus infection-associated antigen), aleo reacts 
heterotypically. Some studies of the type specificity of 
separated F'MDV components were carried out by liradish and 
lirooksby (1~60). However, the more recent work of Cowan and 
Graves (1966), has revealed a greater antigenic complexity of 
FMDV infected ti ■eues and tissue-culture harveats than wae 
appreciated at the time and this limits the value of their 
findings. 
The second section of this work presents studies by CF of 
the serological specificity of isolated antigenic components 
of the virue. The importance of the heterogeneity of naturally-
occurring viral antigens used 1~ routine CF tests for typing 
and sub-typing ie aseessed, and the implications of the reeulta 
are coneidered in relation to current knowledge of the etructure 
of the virue. 
Antigenic differentiation of strains has been used in an 
attempt to claesify intra-type variant• into eub-type groupe. 
However the difficulty in attempting to claeeify into discrete 
groupa, etrains whoee degree• of difference are apparently 
continuouely variable hae led to ambiguity and oonfueion. The 
moat important usee of etrain differentiation have been 
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epidemiological, particularly in their application to the 
control of FMD in t h e field; notably in the monitoring of 
endemic situations for the early detection of emergent or 
introduced new sub-types and in the comparison of field strains 
with those incorporated into vaccines. The use of CF tests for 
such purposes can be criticised on the grounds that serological 
differences so determined may not reflect the antigenic differences 
that determine whether or not an animal is protected abainst 
field challenge. 
This criticism is indeed pertinent, ae there is virtually 
no satisfactory quantitative evidence for a correlation 
between differences detected by CF and those manifest by ,ia 
~ neutralisation tests or by animal cross-protection tests. 
Some such evidence is provided in the third section of this 
thesis, together with an evaluation of the use of CF for sub-
type classification of FHDV atraine. 
SECTION 1. THE FIXATION OF COKl'LEKENT BY MIXTUR.E.S OF 
FuOT-AND-MOUTH DISEASE VIRUS ANTIGEN AND ANTIBODY 
1.1. INTRODUCTION 
The uae of CF for the quantitatiTe measurement of 
reactions between antigen and antibody waa pioneered by 
~adaworth and hia co-workers (Wadsworth~•• 192} a, b 
and c). The ba■is of their method was the finding that under 
certain conditions, with either antigen or antibody at a 
suitable fixed concentration, there waa a linear relationship 
between the amount of complement fixed and the amount of the 
other reactant (antibody or antigen reapectiTely.) 
Further atudiea were -de by Mayer and othera. With a 
■ystem of pneumococcal polysaccharide and homologoua antibody, 
Mayer~- (1948) and Oeler J1...li• (1948) confirmed the 
findings of wadaworth'• team, but demon■trated clearly that, 
in antigen excess, the relationship between the amount of 
antiaerum and the amount of complement fixed, although linear, 
waa not directly proportional. HoweTer with antiserum in 
exceas, there waa a direct relationahip between the amount of 
antigen and the amount of complement fixed. 
Oeler and Heidelber&er (1948 a and b) ■tudied homologou■ 
and heterologoua reactions between pneumococcal type III and 
type VIII poly■accharide ■ystema and between chicken- and 
duck-egg albumin ■yatema. 'l'hey ahowed that homologous and 
heterologous reactions could be differentiated by meaauring 
the amount of complement fixed with a conatant a■ount of one 
antiserum and an opti-1 amount of either homologou■ or 
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hetero1ogouB antigen. The homologouB reaction was genera11y 
greater although the difference between two antigens was not 
necesBarily apparent witn both antisera. 
~a11ace .!!...!!• (1950), using a system of crystalline 
bovine serum albumin (BSA) and rabbit anti-BSA serum, studied 
the extent of complement-fixation ae a function of the amount 
or antibody. When antibody wae reacted with antigen at an 
optimal dilution (that giving maximum fixation of comp1ement) 
the re1ationahip of the amount of complement fixed to the 
amount or antibody could be described by a sigmoid curve. 
They concluded that in their syBtem, the moat satisfactory 
end-point determination ot an antiserum titre was the 
estimation of the dilution of antiserum which would fix 50'Jb 
of the complement available in the preaence of the optimum 
antigen concentration. 
From the criteria determined by these varioua workers, 
CF teats have been developed for many microbiological systems 
uaing a standard technique (e.g. Caaey, 1965). The basis of 
the method is to teat a series of reaction mixtures with 
varying antigen and antiaerum di1utiona in• ao-called 
"chequerboard" titration, with a fixed amount of complement. 
From the result• a maximum ••rum titre can be deter■ined 9 
being the higheat dilution of antiserum fixing a defined amount 
of complement. The opti■al antigen dilution can alao be 
obtained, being that producing the ■aximu■ antiserum titre. 
Having determined tbe activities of atandard antigen• and 
antiaera, unknown antigen• can be titrated in known antieerua 
exo••• and unknown •era can be titrated witn a known opti■u■ 
dilution of antigen. 
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CF tests for the type differentiation of FMDV strains were 
described by Cuica (1929) and Traub and Mcihlmann (1943). In 
. 
1Y46, Traub and Mohlmann showed that the test could be used to 
demon■trate variants within a type. Their test waa based on 
the comparison of homologoua and heterologous antiserum titres, 
determined as the highest dilution of a serum capable of fixing 
a defined amount of complement with undiluted vesicular extracts 
as antigen. Brookaby ~- (1948 a) demonetrated strain 
differences by comparing the ability of mixtures of undiluted 
antigen with homologous and heterologoua antisera to fix 
complement, their results being expreaaed as the dose of 
complement required to produce 50',lt, haemolyais. 
Bradish~- (1960 a) and Bradish and Brookaby (1960) 
used CF teat• to study the antigenic component• of FMDV and 
the specificity of their interactions with antiserum. They 
compared titration• of antigen in antiserum excess and antiserum 
in antigen excess for their ability to reveal differences in 
specificity. Finding the latter technique to be more sensitive, 
they carried out antiserum titratione and expressed their 
results as the amount ot complement fixed per unit volume of 
undiluted anti■eru■, on the assumption that the amount of 
complement fixed was directly proportional to the amount of 
antiserum. Croa■-fixation ratios were determined a■ the 
proportion ot complement-fixing activity of the antigen in 
heterologoua oompared with homologous reaction■• Thia method 
wa■ adopted•• the ba■i ■ tor aub-type differentiation in the 
World Reterence Laboratory (aee, tor examples Davie, 19641 
Darbyaoir• ~-• 1972). 
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Roumiantzeff .!.!.....!!• (1965) described a method for the 
measurement of complement fixation by FMDV which was applied to 
the differentiation of strains. (Roumiantzeff et al., 1966). 
These workers used conventional chequerboard titratione of 
antigen and antiserum from which antiserum titres were 
derived. The titres of an antiserum with heterologous and 
homologous antigens were expressed as a proportion, to give a 
quantitative indication of the antigenic difference between the 
etrains. 
In this Section, a description is given of experiments 
carried out to determine the relationships between the amount• 
of FMDV antigen and antibody in a mixture and the amount of 
complement fixed. From the results, a different method is 
pr~po:~d ! o r th• differentiation of FMDV strains by CF and 
application• of the ■etood are deecribed ueing tube• and 
■icroplate er tee ta . 
1.2 MATERIALS AND M~THODS 
1.2 (a) Reagent• 
The preparation of veronal-buffered saline (VBS), 
complement and the aeneitiaed erythrocyte suspension ia 
deacribed in Appendix,. 
The antigen• ueed were 140S preparations, purified from viru• 
harveets by the method deecribed by Brown and Cartwright (1963). 
The method• of viru• growth and purification are deacribed in 
Appendix 2. The etraine ueed were a• follows s -
(i) Two type~ atraine, 06 (OV1) and o1 Lombardy (01Lom.). 
The D\lae ral e ub-e or~pt• denote aeparate eub-type claaaificationa 
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by the World Reference Laboratory; 
(ii) Two type A strains, A6003 and A6900, which had been 
compared by Cl-' previously by Uuerche ~- ( 1972); 
(iii) Three type A~ia 1 strains, being a parent strain, 
Asia 1 C2, and two derived strains, Asia 1 387 and Asia 1 415, 
which had been selected under mutagenic conditions for altered 
electrophoretic mobility. The strains had earlier undergone 
extensive comparative studies (Priston, 1~72). They were supplied 
by Dr. R. ~riston as purified 140S antigens. 
Antisera to the type 0 and type A strains were produced in 
guinea piga following the method of Brookeby (1952) (Appendix 3 (a)). 
11ntiaera to the Aaia 1 atraina were provided by Dr . R. Priaton . 
They were produced by inocula ting suinea pig• once only with crude 
tieaue culture barveata a nd bleeding the■ 28 days later. Before 
uae the antiaera were inactivated tor JO ■inutea at 56°c . 
1 . 2 \b) Protocol of the Teats 
In tube teats, the reaction mixtures were prepare4 1n 
disposable spectrophotometer cuvettes (Walter Sarstedt (U.K.) Ltd., 
Leicester) ot 1 cm. path length and 3.5 ml. capacity. Addition ot 
all reagents was performed with the tube• in a water bath at o0 c, 
using fixed volume micro-pipettes (Eppendorf Geratebau Netheler u. 
Hinz GmbH, Hamburg, Germany). Antigen, complement and antiserum 
were added in that order, each in a volume or 500pl. In control 
mixtures, reagents were replaced a■ approµriate by the addition or 
the ■ame volume of VBS in the same order. The mixture• were then 
incubated in a water-bath tor 30 minutes at 37°c and senaitiaed 
erythrocytes added in a volume or 1000pl. After a further 
incubation tor 45 minute• at 37°c, the tubea were chilled and 
c entrifu1ed a t 6vo • • for 10 minutes to ■ediment unlysed cell■• 
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The OD of each mixture waa then measured at 541 nm. and the 
proportion of lysis calculated relative to that in control tubes 
showing 100"/4 lysis (OD• 0.600 1 0.010). 
The amount of complement fixed in each reaction mixture 
showing lysis between 10'~ and 90'/4, was calculated using the 
formula of von Krogh (1916), viz. 
log x • log k + (1/n) log y/(1 • y), 
where x = the amount of complement remaining ef+.er primary fixation, 
k • the amount of complement required for 50;\', haemolysis 
(1 C1 H50), 
1/n • a con■tant and 
y • proportion of erythrocytes lysed. 
The value of 1/n was determined for the system by measuring 
the degree of haemolysi■ resulting from the addition of graded 
amounts of complement. It was establi■hed that 1/n •aried between 
0.18 and 0.2Z and a con■tant value of O.ZO was used. The value of 
k w~s calculated ueing the same formula, from complement control 
mixture■ where x wa■ taken as the amount of complement added. 
Microplate teat ■ were performed in wells in pla■tic plate ■ 
(Linbro - Biocult, Biocult Laboratories Ltd., Glasgow) in a final 
•olume of 125pl. The conditions used were de■igoed a■ far aa 
pos■ible to parallel tho•• u■ed in tube te■ te. Thus, the reagent■ 
were added in the same order, all in 1/20 o~ the vol\Ule uaed in 
tubes (antigen, complement and antise~um, 25.)ll•I senaiti■ed 
erythrocyte■, 50pl.) All dilution■ were made in bottle• and the 
reagent■ added to the plate■ witn calibrated dropping pipett••• 
Mixture■ were incubated in a hot-air incubator for 60 minutes prior 
to the addition of ■en■itiaed erytbrocytee, which waa followed by 
a further inc~bation at }?0c tor 45 minute• and then centrifugation 
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at 600 g. for 5 minuttR to sediment unlysed cells. It was 
established by carrying out comparative tests in para•llel, that 
primary fixation under these conditions was similar to fixation in 
tubes after 30 minutes in a waterbath at 37°c. The tests were read 
by visual estimation of the size of deposited erythrocyte buttons. 
1.3 REoULTS 
1.3 (a) A Model for the Fixation of Comnlement by Purified 
140S Antigens and Antiserum 
In order to elucidate the relationships of complement-fixation 
to the concentrations of antigen and antiserum, CF tests were 
carried out using a fixed dose of complement (about 1.2 c•H50 ) 
and Tarying amounts of antigen end antiserum. In these experimente, 
dilution series of the reagents were prepared using grade A 
serological pipettes and the teats were performed in tubes. Tbe 
antigens were purified 140s co■ponents of FMDV etrains OV1 and 
o1 (Lom) and the antiserum was guinea pig serum produced against 
live guinea pig-adapted uV1 virus. The results are illustrated in 
Figures 1.1 to 1.5, the first four figures being homologous reactions 
with the 0V1 strain. 
(1) Variation of amount of anti~en with constant antiaerum 
Figure 1.1 show• the effect• of varying the aaount of antigen 
in a series of mixtures, each with the amount of antiserum conetant. 
For any curve representin~ constant antiserum, the response to 
increasing antigen is at first a linear increase in the amount of 
complement fixed, followed by a region of maximum fixation where 
the proportion of antigen to antibody is optimal and then a range 
of relative antigen excess with a progreeeive decrease in fixation. 
s-ller amounts of antibody gave a shallower elope in the zone of 
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Figure 1.1. The effect of varying the amount of antigen on the 
amount of complement fixed. Each curve represents a constant 
amount of antiserum. 
linear response and resulted in a lower maximum fixation. 
The linear response is in the region of antiserum excess 
and it is apparent that under these circum gtances the relation-
ship of amount of antigen to the amount of complement fixed is 
directly proportional. In the region of maximum fixation the 
slope is small, so that the optimum amount of antigen for a 
particular amount of antiserum is poorly defined. HoweTer it is 
clear that the amount of antigen which is optimal, increases 
with an increase in the amount of antiserum in the mixture and 
with the amount of complement fixed. The broken line in Figure 1.1 
suggests tne possibility tuat the relationship is linear. '!'be 
line was ao placed to pass through points with an almost constant 
ratio of antigen to antiserum (Table 1.1), and it appears 
reasonable to assume thaL these points represent optimum amounts 
of antigen. 
Table 1.1 A■ounts of antiiten and antiserum in optimum 
proportion mixtures. deriYed from Figure 1.1 
Amount ot Amount ot Ratio ot 
antigen {Jil) antisl!rum (J,11) antigen:antiserum 
o.l+o 0.080 5.0 
0.1+7 0.096 1+.9 
0.58 0.115 5.0 
o.n. 0.138 5.0 
0.83 0.160 5.0 
(ii) Variation of amount of antiserum with constant an~ 11en 
figures 1.2 and 1.3 represent the effect of varying the 
amount of antiserum in a series of mixtureR, each containing 
constant antigen. Figure 1.2 is derived from the same experiment 
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Figure 1.,. The relationahip of the amount of antiaer\1111 to the 
amount of complement fixed. The li~es represent constant 
antigen amounta over a range from cloee to optimal to a greater 
than fourfold antigen exceaa. 
as Figure 1.1 and examination of Figure 1.1 will reveal that the 
lines of constant antigen amounts in Figure 1.2 of 0.25 pl., 
0.11 pl. and o.05p1., represent antigen below the optimum over 
the range of amounts of antiserum used. while these curves are 
sigmoid, the lines representin~ 1.25 Jll• and 0.5bpl. of antigen 
are linear over a large part of their range and are almost 
parallel. 
Figure 1.3 from a separate experiment, shows lines of constant 
antigen amounts from 3.1 J.ll•, which was close to optimal over the 
range of antiserum used, to 15.6Jil., which represents a greater 
than four-fold antigen excess. The linear response to increasing 
antiserum with constant antigen is apparent, ae is the parallelism 
of all but one of the lines. 
It is evident from Figures 1.2 and 1.3 that the relationship 
of complement fixed to amount of antiserum, although linear under 
certain conditions, is not one of direct proportionality since 
the lines do not pass through the origin. 
(iii) Variation of amounts of antigen and antiserum while 
maintaining them in optimal proportions 
Figure 1.4 is derived from Figure 1.1 by plotting the points 
of maximum fixation of complement for each level of antiserum. 
The graph indicates a linear response between t he amount of 
complement fixed and the amount of antiserum in each optimum 
proportion mixture. It demonetrates that, at least within this 
range of fixation, 1inear interpolation or extrapolation from two 
or more point• could be used to ascertain the amount of antiserum 
required to fix a certain defined amount of complement in the 
presence ot an optimum amount ot antigen ■ If the amount ot 
1·0 
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Fi~e 1.4. The relationship of the amount of antiserum to the 
amount of complement fixed in the presence of an optimal 
amount of antigen. 
complement is taken as 0.5 c •tt50 (0.69pl. in Figure 1.4), then 
0.13b pl. of antiserum in a volume of 500 J,11• is required to fix 
this amount of complement, i.e. the antiserum titre can be defined 
ae 0.138/500 or 1/ }623. 
(iv) Reactions with homoloKous and heterologous antigens 
~xperiments carried out using a strain-heterologous antigen 
(01Lom. antigen with OV1 antiserum) demonstrated that a similar 
pattern or fixation occurred. However a greater amount or 
antiserum was required in the heterologous system, compared with 
the homologous eystem, for the same level of maximum complement 
fixation. Homologous and heterologous antigens in suitable 
ranges of serial two-fold dilutions were eacb tested against 
two levels of antiserum, pre-titrated to give maximum complement 
fixation in the desired range. The amount of complement fixed in 
each mixture was calculated and curves analogous to those of 
Figure 1.1 were drawn for both antigens at each level of antiserum. 
From these curves the amounts of complement fixed with optimum 
antigen were determined and plotted (Figure 1.5). The antiserum 
titres for the bomologoue and heterologous reactions were then 
found by linear interpolation as deacribed above. Thus, tbe 
antiserum titre with homologous antigen (1/3677) was greater 
than with the heterologous antigen (1/141 6 ). 
1. S ( b) Di f'f'erentiation of FMDV Strains in 'fube and Microplate 
Using the principles of CF demo ~atrated in the system 
described above, comparative tests were c~rried out in tubes and 
in microplatea, to evaluate tbe applicability of the method to 
~MVV strain differentiation. 
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Figure 1.5. The graphical estimation of titres of 06 (OVl) 
antiserum vi th homologo1.111 and hetel"ologous ( o1 Lombardy) 
antigens. 
To compare two strains in a tube test, each antigen was 
used in a series of two-fold dilutions over a pre-determined 
ran6 e which would demonstrate an optimum dilution giving maximum 
fixation. Antisera to each strain were tested at two dilutions 
against each antigen, witn the amount of complement constant at 
approximately 1.2 c•H50 • 
Suitable control mixtures were included in all tests, 
comprising complement alone and complement plus antigen or 
antiserum, at the dilutions used in the test. The amount of 
complement fixed with the optimum dilution of antigen against 
each uilution of antiserum was calculated and appropriate 
corrections made for pro- or anti- complementary activity in 
control mixtures. The titres or each antiserum with both 
antigens were then determined graphically as described above 
in Section 1.3 (a). 
Comparative microplate tests were carried out using 5C'H50 
as the constant complement dose, established by pre-titration in 
plates and equivalent in concentration to 5C'H50 in the tube 
test. Control mixtures were again included in all tests with 
complement at 5, 2.5 and 1.25 c•H50 alone and with antigens and 
antisera at all dilution• used in the teat. 
To compare two atrains in a microplate test, each antigen 
was used in a series of two-fold dilution&, as in the tube tests, 
and tested against each antiserum in a aeries or 1.5-rold or 
two-fold dilutions. The anti ■erum titre was determined as the 
dilution or ••rum which fixed ~ or the 5 c•H50 with an optimum 
amount or antigen, i.e. the bighe■t dilution or antiserum in 
wnich 5o,i, of the ■enaitiaed erythrocytes remained unlysed. #here 
,, 
necessary, interpolation between two wells containing more 
than 50!!, and lees t han 50'~ of unlysed cells was made by 
expressing the antiserum titre as the geometric mean of the 
two dilutions. 
To obtain a quantitative estimate or the relationship 
between two strains, the method used was that described by 
Ubertini .!.t..!l• (19b4) and popularly applied since then to 
FMDV strain differentiation ■ 
For two antigens,! and~• and their respective antisera, 
~and.!!_, the following values are determined:-
£ 1 (antiserum~)•~ 
~ 
where~ represents the reciprocal of the titre of antiserum 
a with the heterologoue antigen and~ represents the reciprocal 
or the homologous titre of the same antiserum; 
similarly, i:2 (antiserum!!_)•~ 
The antigenic relationship between the strains (1) is then 
determined by the formula 
~ • 100 {<J:1 -~> % 
{i) Comparative patterns in tube and microplate teat• 
In all of the teats carried out, the pattern of fixation 
in microplatee was comparable to that in tub••• a■ illuatrated 
by Table 1.2. An optimum dilution of antigen waa always 
demonatrable in tube teata. Howeyer, in microplate test• the 
antigen optimum was often represented by a range of dilution•, 
probably owing to the semi-quantitatiYe nature of the end-point 
determinations in microplates. 
Table 1.2 Comparative com~lement-fixation tests in tubes and 
microplates 
(a) Microplate teats - the numbers represent a visual score 
of t r.e percentage of erythrocytes remaining unl.yaed: 
4 = 100;(,. 3 = 7'fto, 2 = 50'J6, 1 z 2 ,5¾. 
Antiserum (reciprocal of dilution) 
A6003 A6900 
16 32 61+ 128 256 512 16 32 61+ 128 256 512 
32 I+ I+ I+ I+ 
- -
I+ I+ I+ 
- - -
61+ 4 I+ 4 I+ 
- -
I+ 4 4 
- - -
"' 8 128 4 4 I+ 4 2 - I+ 4 4 2 - -\D 
◄ 256 I+ I+ I+ I+ 2 
-
I+ I+ 4 1 
- -
512 2 2 2 2 
- - - - - - - -
32 4 4 I+ 
- - -
4 4 4 4 
- -
64 I+ I+ I+ 
- - -
4 4 4 I+ 1 
-8 128 4 4 4 
- - -
4 4 4 4 1 
-$ 
◄ 256 3 1 1 - - - 2 3 3 2 - -
512 
- - - - - - - - - - - -
( b) Tube tests - the results are shown ae the percentage of 
lyeis in each mixture 
Antiserum (reciprocal of dilution) 
A6003 A6900 
-
1b0 200 520 6~0 240 300 520 650 g 
256 21 59 33 58 ... 
~ 512 15 46 11 36 .... 
... 8 ~ 1024 27 55 18 36 
.... ~ 0 2048 55 08 50 .58 
.... 
~ 4096 70 '1b 71 7' 
J. 
42 Q, 128 24 51 69 ..... 
() 
f! 256 22 47 20 50 
r:I ~ 512 33 54 16 41 
.; \D ◄ 1024 55 60 39 50 
... 
65 69 r:I 2048 71 75 ◄ 
Where inhibition of fixation in antigen excess was not 
observed in microplate teats, the demonstration of an optimum 
amount of antigen was accepted on the basis of at least two 
antigen dilutions indicating the same maximum antiserum end-
point. 
The results shown in Table 1.2 also indicate that in both 
systems, the optimum dilution of an antigen was generally very 
similar for two different antiaera, always being within one 
two-fold interval for both. Thia was a consistent finding in 
all tube and microplate tests discussed in this Section. 
(ii) Reproducibility of results 
Tables 1.3 and 1.4 summarise the results of microplate and 
tube tests respectively. The ranges and mean values of the 
serum titres and of Land! were obtained from the values for 
individual teats and, where microplate teats were performed 
with replicatee, the values for Land! were derived from all 
combinations of the appropriate replicate titres within each 
teat. 
The range of variation in the results was lower in tube 
teats than in microplatea. The maximum variation from a mean 
value for,!, as a percentage of the mean, was ?°Pin tube teate 
and 43% in microplate tests. The values for~ in comparative 
teats were slightly greater, but not significantly so, in 
microplate teats than in tube teats. 
lt is apparent that th• ran~• of variation in an antiserum 
titre in tube teats was greater than the variation in a value 
for i• lt appeared that the main eource of variation in anti-
serum titres wae a variation in the susceptibility of different 
Table 1.3 Antiserum titres and values for L a n d ~ obtained 
in microplate tests 
( 1) 
(2) 
Parameters are shown as mean values with the range 
in brackets 
Antigen 
OV1 
o1Lo11 
o1Lom 
OV1 
A6003 
A6900 
A6900 
A6003 
(1) OV1 versus o1Lom. (three tests, two in 
duplicate) 
(2) A6003 versus A6900 (two tests, one in 
duplicate and one in triplicate 
Antiserum Antiserum titre !: 
OV1 1072 (99'+-1220) 
0.54 (o.44-o.66) 
OV1 575 (441-661) 
o1 Lom 562 (}97-661) 0.30 (0.30) 
o1 Lo111 H,6 (118-196) 
A6003 272 (256-362) 
0.36 (0.25-0.50] 
A6003 97 (91-102) 
A6900 288 (256-324) 
0 • .50 (0.3.5-0.71 ) 
A6900 145 (128-162) 
l! 
4o;., 
( 35-47"/4 ) 
42",.;, 
(30-60P/4 ) 
Table 1.4 nti■tru■ titre■ and valuee for L ~ ! obtaintd 
in tube teats 
(1) 
(2) 
(3) 
(4) 
Para■eters are shown as mean values with the range 
in brackets 
(1) OV1 versus o1 Lo■• (4 tests) 
(2) A6003 veraua A6900 (3 tests) 
(3) Aaia 1 c 2 Teraus Asia 1 415 (} teat■ ) 
(4) Aaia 1 c 2 veraus Asia 1 387 (2 teats) 
(5) Aaia 1 415 Tersus Aaia 1 387 (2 tes ts ) 
Antigen Antiaeru■ Antiaerum titre ~ ! 
OV1 OV1 }548 (2564-3846) 
0.37 (0.}4-0.42) 
o1Lo11 V1 1}18 (1097-1429) }0% 
(28-}2% ) 
o 1 Lo■ o 1 Lo■ 1862 ( 1724-1887) 0.26 (0.23-0.26) 
OV1 o1 Lo■ 447 (427-485) 
A600} A6003 589 (552-602) 
0.28 (0.28-0.30) 
A6900 A6oo:, 166 (153-178) 
37% 
A6900 A6900 562 (538-658) (}6-3~) 
o.49 co.47-0.52) 
A6003 i.6900 295 (281-}11) 
Aeia1 c 2 Asia1 cz 195 (180-213) 1.00 (0.97-1.04) 
Aeia 1 Asia1 CZ 195 ( 174-221) 
415 8Y,: (82-8 ) 
Aeia 1 Aaia 1 145 (127-152) 
415 415 0.69 (O.b7-o.71) 
Aeia1 c2 Aaia 1 105 (94-122) 415 
Aeia1 c2 Aaia1 c2 195 (180-213) 0.95 (0.95) 
Aei& 1 Aaia1 CZ 191 ( 177-202) 
387 101 (100-101~ 
Aaia 1 Aaia 1 85 (79-100) 
387 387 1.07 (1.06-1.08) 
Aaia1 C2 Aaia 1 95 (8b-10) 38? 
/Table continued overleaf 
Table 1.4 Continued 
Antigen Antiserum Antiserum titre r H 
(5) Asia 1 Asia 1 145 (127-152) 
415 415 
o.64 co.62-0.6~) 
Asia 1 Asia 1 87 (81-94) 
387 415 
8'1,\, 
(78-83",i) 
Asia 1 Asia 1 85 (79-100) 
387 387 
1.00 (0.99-1.00) 
Asia 1 Asia 1 89 (78-99) 
415 387 
batches of erythrocytes causing the value of 1C' H50 to vary 
considerably between tests, only when different batches of 
erythrocytes were used. The values of~ and! were affected 
much less by these errors, since they arP. proportional values. 
In the microplate tests of OV1 y. o1Lom., 1.5-fold antiserum 
dilutions were used. Since the range of variation of antiserum 
titres within tests was similar to those for tests of A6003 i• 
A6900, in which two-fold antiserum dilutions were used, it would 
appear that there is no advantaee in using the closer dilution 
interval. 
(iii) Anti,;enic relationships of the straine 
From tests in tubes, the mean values for i between UV1 and 
o1Lom. was 30/b and between A6003 and A6900 was 371o. In both of 
these comparisons, antigenic differenc~s were detectable with 
either antiserum but were quantitatively different, i.e. the 
values of ~ 1 and L2 were unequal. 
Two of the Asia 1 strains appeared to be identical (Asia 1 C2 
~• Asia 1 387, i • 101%) and the third strain, Asia 1 415 was 
different but held a similar relationship to both of the other 
two (Asia 1C21• Asia 1 415 ! • 83%; Asia 1 387 ~• Asia 1 415 
! - 80'.-,). 
There was very little difference in the titres of either 
the Asia 1 C2 or the Asia 1 387 antisera when teated against 
any of the three etraine, so that antigenic differences between 
the strains wa■ detectable only with the Aaia 1 415 antieerum. 
The two values for~ obtained with this antiserum were of the 
same order (A■ia 1 415 ~• Asia 1 C2 ~1 • 0.691 Asia 14151• 
Asia 1 }87 £i • o.64), which confirms the virtual identity of 
the Asia 1 C2 and Asia 1 387 strains. 
As the antisera to the Asia 1 strains were prepared using 
crude tissue culture antigens, it was possible that antibody to 
BHK cellular material could react with contaminating cellular 
debris. However, the method of antigen purification used should 
exclude host material and there was no fixation of complement by 
any of the three antisera, teated at the lowest dilutions used, 
against a similarly purified heterologous (type 0) anti E;en. 
1 .4 DLiCUS5 ION 
The results in Section 1.3 (a) suggest a model for the 
fixation of complement in this system which is consistent with 
those obtained by other workers, using more precise methods in 
more closely defined systems. While the 14OS component of FMDV 
is antigenically complex and the antiserum uaed in these 
experiments can react with a number of different antigenic 
sites (see Section 2), it would appear that complement fixation 
proceeds in a similar manner to that described by Oeler!!......!!• 
(1948) uein6 a single antigen/antibody system (pneumococcal 
capsular polysaccharide). Shulmari ( 1958) alao provided 
experimental and theoretical evidence for a model of complement 
fixation by complexes of antibody, quinidine as a haptene and 
platelet•, with atrikingly similar characteristics. 
However, the assumption made by Bradish~• (1960 a), 
that in anti g en exce us there is a relation■hip of direct 
proportionality between the amount or antigen and the amount 
of complement fixed is contrary to these reaulta. Since 
satisfactory experimental evidence for their assumption 1• 
lacking it must be concluded that there is no valid basis for 
the CF teat devised by these workers for FMDV strain differ-
entiation. 
The estimation of an antiserum titre, as described above 
in relation to Figure 1.4, is the basis of conventional 
chequerboard titrations. The response shown between the amount 
of antiserum and the amount of complement fixed is probably 
sigmoid ( 'Nallace ~-, 1950; de Almeida ~-, 1952; 
Shulman, 1958) but the data in Figure 1.4 suggest that in 
this system it is reasonable to assume linearity over the range 
of fixation used. The use of onl y two points on this line (as 
in Figure 1.5) to determine an antiserum titre introduces the 
possibility of error in the estimate but was justified on the 
basis of technical simplicity. If the error in position or the 
points ie emall and large extrapolation is avoided, the error 
in the estimate of the antiserum titre should in practice be 
acceptable. 
As shown in Figure 1.5, an antiserum will have a lower titre 
when reacting with a beterologous antigen than with its homologous 
antigen. It would appear that the expreesion of a difference 
in titres as a proportion {i.e. beterologoue titre/homologous 
titre) is a valid and eeneitive method of meaeuring the 
relationehip between two antigen•• Thie expreasion was the 
baeis of the technique for differentiation of FMDV •trains by 
Roumiantzetf ~• (1965 and 1966) in a eyatem uaing 5c 1 H50 ae 
the conatant complement dose, and unpuritied virus barveate for 
antigen. Tbe uee of a lower do•• of complement a• deacribed 
tor the tube teat• in tbia &ection enable•• ■ore accurate 
meaeurement of residual complement in antigen/antieerum mixture• 
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compared with that in antigen, antiserum and complement control 
mixtures. 
The comparative results of tube and microplate tests 
illustrate the essential difference between the two methods. 
Microplate tests, while simple and rapid to perform and to 
replicate, are considerably less reproducible than tube tests 
which, however, require considerable care in the preparation 
and pre-titration of reagents. It would appear that the error 
in microplate tests would be quite acceptable for the routine 
differentiation of field strains of FHVV if the tests were 
sufficiently replicated. However the tube test provides a 
sensitive and accurate method for the detection of small 
antigenic differences. 
Guerche J.1..!!• (1972) found that the two type A strains, 
A6003 and A6900, could not be differentiated by complement 
fixation. Since they found that the two strains were immuno-
logically distinct, they concluded that complement fixation 
was an unsatisfactory method for detecting immunological 
variants. These authors used a complement fixation test in 
tubes in which the concentrations of antigen, antiserum and 
complement were all varied. Their results were not entirely 
consistent with the model o:f fixation descri!:led in this Section 
but this could be explained by their use of crude tiasue 
culture harvests aa antigen•, since these will contain at least 
three complement fixing antigen•, probably at different concen-
trations and with different atrain specificities, as described 
in Section 2. The value for j, determined in this section 
(j • 37"~) waa of a similar order to that for the two type u 
atraina (j, • }O'ii,) which are classified in the ·.world Reference 
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Laboratory as different sub-types. It can only be concluded 
from this that the two strains, A6003 and A6900 are serologically 
distinct. The strains were used for further immunological 
studies, described in Section 3. 
~he differences between the type Asia 1 strain 415 and the 
two other strains, C2 and 387 0 were small but reproducible and 
in the light of the interrelationships between the three strains, 
would appear to be sisnificant. It was demonstrated that the 
close similarities were not the result of fixation of complement 
by contaminating non-viral anti gens. Nor is it likely that 
viral antigens other than 1408 were reacting since otber work 
(Section 2) sug gests that such anti ~ens - in particular, 12S 
sub-units resulting from degradation of the virion - are present 
in such preparations at only very low levels. These differences 
could, however, not be correlated with any of the other criteria 
by which the strains have been compared (Priaton, 19?2). 
1.5 CoNCLU§lONS 
It has been shown that the fixation of complement by FMD 
virus and antibody in the system describeu follows the same 
principles as models developed in closely defined single antigen/ 
antibody systems. 
The concept of direct proportionality between the amount of 
complement fixed and the amount of antibody in antiben excess 
appears to be incorrect. 
lt was demonatrated that FHDV strains can be satisfactorily 
differentiated in Cf teats, when the result• are expressed as 
relationships derived from antieerum titre• with a fixed amount 
of complement and optimum amounts of homologous and heterologoua 
antigen•• 
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The results obtained vith tests carried out in microplates 
and i n tubes are comparable, but in the latter case are more 
reproducible and provide a precise method for the identification 
of small antigenic differences. 
SECTION 2. THE SEROLOGICAL ACTIVITY OF ANTIGEN!~ CO~PONENTS 
OF FOOT-AND-MOUTH DISEASE VIRUS 
2 .1 INTRODUCTION 
2.1 (a) The Structure of FMllV 
The first measurement of the size of FMDV by Galloway and 
Elford (1931) gave an estimate of the size of the infective 
particle of 8 to 12 nm. The same authors later re-estimated the 
eize as about 20 nm. (Elford and Galloway, 1937). 
Traub and Pyl (1943) and Hohlmann (1943) demonstrated that 
centrifugation under conditions that sedimented 99'Jb of the 
infectivity of a virus harvest, removed only 50 to 7':/to of the 
complement-fixing activity from the supernatant. Similar 
findings by Bradish .!.l...!!• (1952), led them to postulate the 
existence of two complement-fixing components, the larger one 
(estimated as 20 nm.) being associated with all or mo■t of the 
infectivity and the smaller component (estimated to be 7 nm.) 
possessing no detectable infectivity. Bradiah et al. (1960 b) 
re-estimated the size of the infective component as about 25 nm. 
The two components ahall be referred to by their sedimentation 
coefficiente, the most reliable eatimates for these being 140S 
for the infective particle (Trautman.!!...!.!•• 1959) and 12S for 
the ■-ller component (Talbot and Hrown, 1972). 
Bradish and Brookaby (1960) demonetrated that ther-1 
degradation of the 140S component produced a emaller unit which 
behaved similarly in CF teats to the naturally occurring 12S 
component and Brown and Cartwright (1961) produced a ■imilar 
component by mild (pH 6.5) acid disruption of the virion. 
In 1968, Vande Woude and Bachrach found that dierupted 
viru• aeparated into multiple bands on polyacryla■ide gel 
electrophoresis. ~i1d !.!....!!• (1969) provided evidence that such 
bands represented different polypeptides. Burroughs~- (1971) 
demonstrated the separate identity or four polypeptides with 
molecular weights of 34, 30, 26 and 13.5 x 103 in sodium 
dodecyl sulphate polyacrylamide gels. They also showed that 
the 12S component produced by mild acid disruption of the virion 
was deficient in one polypeptide which was identified as the 
major component of a separate aggregate. 
The virion structure of several picornaviruses has been 
studied and a comparative review has been made by Rueckert (1971). 
Talbot and Brown, (1972) proposed a model for FMDV demonstrating 
a close similarity in the structure of this virus with other 
members of the family. They showed that the four polypeptides 
(VP1 to VP4) were present in the ratio of 1:1:1:O.5. In this 
model the virion is compri•ed of twenty 12S sub-units and thirty 
molecule• of VP4. Each 12S sub-unit contains three each of VP1, 
VP2 and VP} and represents one of the triangular faces of an 
icosahedron. The VP4 molecules are aituated singly on the lines 
of appo•ition of the faces of the icosahedron. Within this 
protein capsid is the viral RNA, comprising 31% of the weight 
of the virus particle (Bachrach et al., 1904). 
2.1 (b} Tb• Anti~enic ~roperties of FMD Viral Component• 
There is ample and convincing evidence that the 14OS virus 
particle ia the moat effective antigenic component for the 
stimulation of neutralising antibody production (Randrup, 19541 
Wild and Brown, 1968). Virus rendered non-infective 1• 
immunogenic provided the capaid remains intact, and the potency 
of inactivated vaccine• derived from some unstable atraina can 
be enhanced by atabilisation of the 14OS particle by treat■ent 
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with formaldehyde (Rowlands~•• 1972; Mowat~•• 1973). 
The antigenic activity of the 140S component is apparently 
type specific. Brown and Crick (1958) found that 140S particles 
gave precipitin lines in a ~ar gel diffusion teats only against 
homotypic antiserum and that the reaction could not be prevented 
by mixing the virus with heterotypic antiserum. Bradish and 
Hrooksby (1960) showed that the 140s component reacts only with 
homotypic antiserum in complement fixation tests. 
However, serological cross-reactions between 140~ particles 
of different sub-types are readily demonstrable. They were 
demonstrated in CF tests with unfractionated virus harvests by 
Traub and Mohlmann (1946) and Brooksby .!!....!!• (1948 a) and were 
identified as a property of the 140S particle by Bradish and 
Brookaby ( 1960}. 
Booth and Pay (1973) demonstrated that virus harvests of 
F~iDV type SAT 2 under certain condi tione haemagglutinate guinea 
pi~ erythrocytes. Purified 140S preparations of different sub-
t ype strains possessed haemagglutinating activity and anti genic 
differences were demonstrable in haemagglutination-inhibition 
teats. 
~xamination of the 12S component, separated from virus 
harvests (natural 12S) or obtained by dieruption of the virion 
(artificial 126) revealed that it had antigenic properties 
related to, but different from those of the 140S component. It 
has a negligible ability to atimulate neutralieinb antibody 
production (Brown 1973) and abaorption of IgO antibody with 12S 
component does not reduce it• neutraliaing activity (Rowlands 
.!.L!!·• 1971). 
Cowan (1968) found that guinea pig• 1-uniaed with either 
140S or 12S components produced antibodies reactive with both 
components. However. Cartwright (1962) and Cowan (1968) 
demonstrated that absorption of antiaera havin& such dual 
reactivity. with an excess of 12S component would reduce but 
not eliminate the anti-140S activity. indicating a partial 
antigenic identity. 
In contrast to the purely homotypic activity of the 140s 
particle• cross-reactions between types are demonstrable with 
the 12S component. Brown and Crick (1958) found that lines of 
precipitation produced in agar gel diffusion teats with 12S 
antigen and homotypic antiserum. could be prevented by mixing 
the antigen with heterotypic antiserum. However. diffusion of 
12S antigen against heterotypic antiserum did not produce a 
visible precipitate. Bradish and Brooksby (1960) showed that 
the type-specific 140S antigen developed heterotypic activity 
in CF tests after thermal degradation. 
Bradish and Brooksby (1960) also examined the sub-type 
specificity of their separated U-fractions (aaaumed to be 12S 
component) and D-fractiona (140S component). They concluded 
from their obaervatione that the 123 component has lees eub-
type specificity than the 1405 component. 
Non-infective. empty capsida which aediment at 75S were 
identified by Graves~• (1968). They differed from 140S 
particle• in beine reaiatant to acid degradation to the 12S 
component, and in reacting with anti-12S eerum which possessed 
no anti-140S activity. Their presence is quantitatively 
eignificant in some virus etraina (up to 85% of the total 
complement-fixing activity in harveata of one of the etraina 
■tudied by Grav•• 11...!l•• 1968) 1 and they atimulate aa much 
neutralising antibody as 140S particles provided they have 
first been fixed with formaldehyde (Rowlands, D.J., Sangar, D.V. 
and Brown, F.; quoted by Brown, 1973). 
Wild and Brown (1967) demonstrated that the treatment of 
FMDV with trypsin considerably reduced its infectivity and its 
ability to stimulate neutralising antibody production, without 
altering its gross morphology. Wild~• (1969) showed by 
agar gel diffusion tests that trypsin-treated virus was less 
reactive than untreated virus with homologous antiserum. They 
also demonatrated that virus treated with the enzyme was no 
longer able to attach to susceptible cells. Burroughs li..!!• 
(1971) and Strobmaier and Adam (19?4) showed that trypsin 
treatment affected only one polypeptide (VF1}. Rowlands~-
(1971) found that trypsin-treated virus only etimulated 1% to 
10% of the level of neutralising antibody produced by untreated 
virus. They concluded that two distinct types of neutralising 
antibody are produced by complete particles and that the major 
one is not stimulated by trypsin-treated virua. 
Booth and Pay (19?3) showed that the hae■agglutinating 
activity of type SAT 2 viru••• was common to both 140S and 75S 
particles but was absent from the 12S component and from 
trypsin-treated 140S particle•• 
Brown and Smale (1970) atudied the reactions of FMDV with 
IgG and IgM by agar gel diffu■ion teats and by eleotron-
micro■copy. They auggeated that the aurface of the virion 
po••••••• three types of combining aite. Qne type of aite 
appeared to be on the faoe• of the particle and wa• common to 
the intact virion, the trypain-treated virus and the 12S component . 
The two other type• of site were situated at regular interval•• 
probably at the icosahedral vertices, but only one was present 
on the trypsin-treated virion and by implication, neither of 
them on the 12S sub-unit. Cowan (1 969) d emonstrated that l gM 
could detect differences between strains in a gar gel diffusion 
tests which were not detectable using lgG. This greater 
differentiatin& ability of IgM was also demonstrated by Brown 
and Smale (1970) since they found that IgM reacted only with 
the antigenic site absent from the 12s and trypsin-treated 
particles. 
In 1973, Talbot et al. demonstrated that the polypeptide 
VP4 from strains of all seven types of FMDV migrated to a 
similar position in polyacrylamide gel electrophoresis 
preparations, although the polypeptide separation patterns 
were otherwise different and characteristic of the virus type. 
They also showed that VP4 reacts with heterotypic as well as 
bomotypic antieera in complement-fixation tests. 
Cowan and Graves (1966) identified an antigen in infected 
tissues and tissue culture harvests which, although specific 
for FHD infection, appeared to not be a structural component 
of the virion. It is possibly an enzyme necessary for viral 
RNA replication and ie termed virus infection-aseociated 
(VIA) antigen. It was found that VIA antigen of type A cross-
reacted in CF teata with antisera of all types except SAT 2. 
In this Section, experiments are described in which 
preparation• of viral antigens were teated by CF. The varicua 
antigenic component• were compared to determine their relative 
potency, their inter-type and intra-type aeroloiical epecificity, 
and the effect on their activity of long and short incubation 
periods in the CF teat. 
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2.2 MATEil lAL.s ANLJ METHODS 
2.2 (a) Antigens 
Antigens were prepared from the following strainss 
type O 
type A 
OV1, 0 1 Lombardy; 
A600}, A6900; 
type SAT 1: RV 11/37; 
type SAT 31 RV 7/}4. 
14os antigens were prepared from virus harvests by 
concentration, pelleting and sucrose density gradient centri-
fugation, as described in Appendix 2 (b). 
75S antigens (RNA-free capsids) were prepared as described 
in Appendix 2 (c), with the final purification again carried out 
by sucrose density gradient centrifugation. 
Preparations of trypsin-treated virus were made by treating 
the re-suspended pellet material with trypsin prior to the final 
purification (Appendix 2 (d)). 
Artificial 12S antigen was prepared by degradin g purified 
virus followed by a further centrifugation through sucrose 
density gradients (Appendix 2 (e)). 
The separation of natural 12S antigen and VIA antigen from 
the supernatant remaining after pelletins the 140s antigen, wae 
achieved by a modification of the method described by Cowan and 
Grave• (1966) using diethylaminoethyl (U~AE)- cellulose chroma-
tography. Sucrose denaity gradient centrifugation waa then ueed 
for further purification (Appendix 2 ( f)) • 
Some of the antigen preparation• were labelled with radio-
iaotopea ae indicated in the text. The methods ueed are 
deecribed in Appendix 2 <•>• 
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2.2 (b) Antisera 
Live-virus antisera were prepared in guinea pi gs by the 
method described by Brooksby (1952) (Appendix 3 (a)). 
Antisera specific for 140S antigen were prepared by 
adsorbing live-virus antiserum with acid-degraded purified 
virus. The method followed was that of Brown and Smale (1970) 
and is described in Appendix 3 (b). 
Anti-140S sera were prepared against purified, inactivated 
140S antigens by the method described in Appendix 3 (c). 
An antiserum was prepared against artificial 12S antigen 
as described in Appendix 3 (d). 
2.2 (c) Complement-fixation Testa 
CF tests tor the assay of sucrose density gradient 
fractions and DEAE-celluloee column elution fractions were 
performed in microplates by standard methods ae described in 
Appendix 4 . 
'l'o evaluate the serological specificity of the antigen 
preparations, CF tests were carried out in tubes using the 
materials and methods described in Section 1.2. Long-fixation 
CF tests were also carried out, in which primary fixation was 
allowed to proceed tor 18 hours at 4°c. All other conditions 
were identical to those for the short-fixation (30 minutes at 
37°C) tests. 
CF t••ts to determine the total complement-fixing activity 
(potency) of antigen• were carried out in tubes, using the same 
protocol as tor the epeoiticity te•t•, with either long or 
ahort fixation perioda. Antigens were tested in two-told 
dilution •eries, again•t a fixed amount of anti•erum at a 
conoentration of at least four times the anti•erum titre Ca• 
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defined in Section 1.3) and a constant amount of complement of 
approximately 1.2 C•H50 • Under these conditions the amount of 
complement fixed is directly proportional to the amount of 
antigen present (Section 1). The antigenic potency was measured 
in complement-fixing units (cfu), one cfu. being the amount of 
antigen in 500 Jl1. which would fix 0.5 c•H50 of complement. 
2.3 RESULTS 
2.} (a) Complement-fixation Tests with 140ci Antigens 
Tests for type and sub-type specificity were carried out 
with 140S antigens purified on sucrose density gradients. Yigure 
2.1 shows a typical gradient profile of complement-fixing 
activity and UV-absorbance at 259 nm. It is evident that the 
virus peak is we11 separated from the slower sedimenting 
cellular contaminants and that the CF teat routinely used ~or 
the assay of sucrose density gradients is a satisfactory method 
of identifying the virus peak. 
Type O (OV1) and type A (A6003) 140S antigens were teated 
for activity against heterotypic antisera (types A and v 
respectively) in CF teats using a fixation period of 1~ hours 
at 4°c. The antisera were used at 100 times the concentration 
of their homologous 140S titre ■• No fixation wa■ detected with 
either of the antigens at the dilutions giYing optimum fixation 
with their homo1ogou• anti ■era. HoweTer, at higher concen-
trations, a yariable amount of fixation waa detected, depending 
on the age of the antigen. A preparation of 140S antigen of 
the strain A6003 tested on the day of purification ■howed no 
fixation with OV1 antiserum except at a concentration 64 time ■ 
greater than the homologous antigen titre. A second 140S 
antigen of the same ■train, tested 7 days after preparation, 
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Figure 2.1. CP' activity and UV abeorbance of fractions from a 
sucrose density gradient for purification of 1405 antigen, 
strain A600:,. 
fixed complement with OV1 antiserum with an anti gen titre only 
16 timee lower than the homologous antigen titre. Because of 
the complete lack of cross-reaction with anti gens at their 
optimum dilutions for homologous reactions anct tne ver -;y hign 
concentrations of freshly-prepared 140S antigen required to 
demonstrate any heterologoua fixation, it was concluded that 
such fixation was due to antigenic sites exposed on degradation 
of the virion with time; i.e. that intact virions have no 
heterotypic CF activity. 
'rhe results of a number of CF teats for sub-type 
specificity were presented in Section 1. Further experiments 
were carried out to compare the sub-type specificity of 
reactions in short-fixation (30 minutes at 37° c) and long-
fixation (18 hours at 4°c) CF tests. The results are shown 
in Tabl.e 2.1 
It is clear from these results that the specificity of 
the 140~ reactions was lower in the long-fixation than in the 
short-fixation teats. This could be the result of a more 
complete cross-reaction between antigen and specific anti-140S 
antibody. Alternatively, it could be a manifeatation of an 
increased croas-reaction between 140S antigen, either intact or 
partial.ly degraded to 12S anti~en, and antibody reactive to both 
140S and 12S anti ~ens. To clarify this, long fixation cross-CF 
teats were carried out between OV1 and o1 Lombardy strains, 
uaing antisera which had been adsorbed with acid-degraded virua 
and which possessed no detectable anti-12S activity. 
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Table 2.1 Comvarative short-fixation and long-fixation 
CF tests for sub-type specificity of 140S antigens 
CF test Antigen ~ntiserum Antiserum J: .!i 
titre 
.Short- OV1 OV1 }659 
fixation 0.}5 
o 1Lom OV1 1271 }0% 
o1 Lom o1Lom 1786 0.25 
OV1 0 1 Lo■ 450 
Long- OV1 OV1 1}846 
fixation o.49 
o 1 Lo■ OV1 6729 41% 
o1 Lo■ o1 Lo■ 6207 0.}5 
OV1 o 1 Lo■ 2167 
Short- A600} A600} 596 
fixation 0.29 
A6900 A600} 171 
3 ?';,, 
A6900 A6900 670 
o.46 
A600} A6900 Jo8 
Long-
fixation A600J A600J 3191 
o.41 
A6900 A600J 1320 
At9" 
A6900 A6900 3168 
0.58 
AbOO} A6900 1852 
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Table 2.2 Comparative cross-CF tests for sub-type specificity 
of 140S antigens using non-adsorbed and 12~-adsorbed antisera 
Type of antiserum 
~1 £2 R 
(OV1) (01 Lom) 
Non-adsorbed 0.50 0.36 4% 
12S-adsorbed o.48 0.35 41% 
The results in Table 2.2 indicate that the reactions with 
125-adsorbed antisera have virtually the same specificity as 
those with non-adsorbed antisera. Consequently, it would appear 
that the decreased specificity in the long-fixation tests is the 
result of a more complete cross-reaction of the 1403 antigen with 
140S-specific antibodies. 
The 140S antigens of the OV1 and o1 Lombardy strains were 
aleo compared in long fixation CF teats using anti-140S sera. 
The results were ae follows: 
L, (OV1) 
~ (o1Lom) 
E 
• 0.37 
Although th• value for L, was significantly lower, the overall 
relationship,!, was similar to the values determined with the 
live-virus antisera. 
The reeult• ehown in Table 2.1 indicate that antiserum 
titrea to 140S antigen were considerably greater in long-
fixation than in abort-fixation te ■ts. As a mean of the four 
homologous reactions ehown in this Table, the antiserum titre 
in a long-fixation teat was greater by a factor of 4.5 than the 
correeponding titre in a short-fixation te■t. 
A ■ample of purified 1406 antigen wae te■ted for antigenic 
potency in long and ahort fixation te■ts. The values obtained 
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weres 
Long-fixation 
Short-fixation 
7194 cfu. 
1613 cfu. 
Therefore the potency determined by a long-fixation test was 
4.5 times greater than t 11at determined with short-fixation. 
2.~ (b) The Sub-tv~e Specificity of Empty Capsids 
Bmpty capsids (75S anti gen) of the strain A6003 were 
compared with 140S antig en of the same strain for sub-type 
specificity and for antigenic potency. 
Three preparations of 75S antigen were made and compared 
in three separate experiments with fresh preparations of 14os 
antigen. In one experiment, the virus was g rown in the presence 
of 14c-labelled amino-acids and 3H-labelled uridine to determine 
the relative antigenic potencies of the two particles, and to 
ascertain the maximum degree of contamination of the 75S antigen 
with 140S antigen (the reverse was not a problem, since the SDS 
used in the 140S purification procedure destroys 75S particles; 
D.J. Rowlands, personal communication). Figure 2.2 shows 
sucrose density gradient profiles of this preparation in terms 
of the 14c and 3H activity of the fractions. 
Since the 14c-labelled amino-acids are incorporated into 
the viral capsid and the 3H-labelled uridine into the viral HNA, 
the lower peak in Figure 2.2 represents intact virus and the 
upper peak, empty capsids. This was confirmed by calculation 
of the sedimentation rate of the higher peak. Assumings linear 
gradient, and a value of 140S for the lower peak, a value of 75S 
is obtained for the higher peak. The complement-fixing profiles 
of this gradient and of the other two preparative gradients for 
75~ antigen were essentially tile same•• tbe 14c-activity profile 
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of Figure 2.2. 
3 14 The ratios of H: C activity in the 140S and 75s peaks 
of the double-labelled preparation were 2.91 and 0. 6 7 respect-
3 14 ively. Thus the ratio of H: C activity in the 75S peak is 
only 23% of that for the 140S peak. If these activities were 
due only to radio-isotopes incorporated into virus particles, 
the value of 2-:h, would represent the amount of contamination 
of the 75S antigen with 140S particles. However, the profile 
of activity throughout t he gradient would suggest that the 
majority of the 3H activity in the 75S region was the result 
of unincorporated label. Consequently the degree of contam-
ination was probably mucn less than 2~. lnfectivity titration• 
by plaque assay (Appendix 6) gave values for the 140s and 75S 
peaks of 109 • 2 and 107•3 pfu./ml. respectively. The ratios of 
infectivity: 14c activity in the two peaks were 1.9 x 106 for 
4 the 140S and 9.1 x 10 for the 75S peak. This indicates that 
the degree of 140S contamination of the 75S peak was 9.1/190, 
or approximately 5',11,. 
In each of three experiments, 75S antigen and 140S antigen 
were teated by short-fixation CF tests in tubes, against the 
homologous antiserum, A6003 and a sub-type heterologoua anti-
serum, A6900, to compare their sub-type specificity. The results 
are shown in Table 2.3. It can be seen that the titrea of each 
anti s erum with either 1405 antigen or ?5S antigen waa virtually 
identical, 1.e. the two antigen• were equally reactive and had 
the same sub-type specificity. 
Table 2.; Homolo~ous and heterologous antiserum titres with 
FMDV strain A6003 140S and 75S anti5ens 
Antigen Antiserum Antiserum titre 
Expt. 1 Expt. 2 Expt. 3 
140S Ab003 546 524 543 
75S A6003 542 524 538 
140S A6';00 256 28b 271 
75S A6900 243 283 262 
To determine the relative complement-fixine potency of the 
140S and 75S antigens, the radio-actively labelled preparations 
were assayed for total CF activity. lt is evident from Table 2.4 
that the ratio of 14c activity was virtually identical to that 
of the CF activity of the two antigens. 'rhis sugg&sts that 140S 
and 75S particles have the same capability for fixing complement. 
Table 2.4 14c activity and CF activity of FMDV strain A6003, 
1403 and 75S antigens 
14 C activity CF activity 
(ct./min.) (cfu.) 
140S antigen 8294 7.87 
75S antigen 2213 2.08 
Ratio 3.75 3.78 
In the light of the virtual identity of the CF reaction■ 
with 140s and 75s antigens, it can be assumed that a small 
amount of contamination of the 75S anti gen with 1403 particles 
would not have affected the results. ln the eub-type specificity 
tests, the fact that the A6900 antiserum titres were very slightly 
lower with the 75s antigen may be significant. ~~pty capeids are 
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leas stable than intact virions (D.J. Rowlands, personal 
communication), and a small de gree of breakdown could alter 
the antigenic character of t he particles, causing an altered 
reactivity with this antiserum. 
2.3 (c) The Sub-type Soecificity of Trypsin-treated Virus 
~urified trypsin-treated 140~ antigens (T-140S) were 
compared with normal 140S antigens of the same strain, for sub-
type specificity. Three preparations of OV1 antigen and one 
of o1 Lombardy were made and for each preparation the effect-
iveness of the trypsin-treatment was verified by demonstrating 
a decrease in infectivity of at least 103•0 pfu./ml. of the 
treated part of a divided sample, compared with the untreated 
part. 
One preparation of the OV1 strain was labelled with 
35s-methionine and experiments were carried out to confirm more 
fully the quantitative conversion of the virus to trypsin-
treated particles. Samples of purified 140$ and T-140S antigens 
were dissociated under denaturing conditions and the polypeptide• 
were separated by polyacrylamide gel electrophoresis (Appendix5 ) . 
Preparation and electrophoresis of the gels was kindly carried 
out by Dr. H.G. Pereira. The gels were analysed by autorad-
iography and the developed autoradiographs scanned with a micro-
densitometer (Joyce, Loebl & Co. Ltd., Gateshead). The profiles 
obtained are shown in Figure 2.3 and they demonstrate that on 
trypsin-treatment a new polypeptide is obtained (VP1T) and that 
there is a decreased density of the peak consisting of VP1 and 
Vi'2. This is consistent with the evidenc .. of •.iild ll..!J:• ( 1969) 
and liurrougns ~• (1971) that treatment wit i. the enzyme 
affects only VF1. 
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Figure 2 .3. Polyacrylamide gel electrophoresis of strain OVl, 
(a) virus and (b) trypsin-treated v i rus . Mi ~ration from 
left to right. 
(a) VP VP 
1+2 3 
l l 
VP VP VP 
2 3 1(T) 
l l l 
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VP 
' l 
VP 
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Further evidence for the completeness of conversion to 
T-140S was obtained in an electrophoretic mobilit y experiment 
carried out with the assistance of Dr. R.A .J. Priston. The 
method is described in Appendix 7 and separation of proteins is 
obtained on the basi s of their charge. 1 lectrophoresis columns 
were run concurrently with 140S and T- 140S samples 9 fractionated 
and analysed for radio-activity. The profiles shown in Figure 
2 .4 are characteristic of those obtained with normal and trypsin-
treated particles of the OV1 strain ( Priston. 1972). The lack 
of any activity in the T-140~ profile in the region of the peak 
in the 140S profile• confirms that the virus had been quantit-
atively converted to T-14os. The divided nature of the T-140S 
peak is probably due to breakdown of the antigen to 12~ sub-
units, since trypsin-treated virus is relatively unstable 
(D.J. Rowlands, personal communication). However, it is unlikely 
that such degradation occurred in the CF tests to any large 
extent since, unlike the CF test, the conditions of the electro-
phoretic mobility experiment (1 8 hours at 25° c) would favour 
deterioration of the antigen. 
Short-fixation CF tests were carried out with 140S and 
T-140S antigens against homologous and sub-type heterologous 
(u
1
Lom for UV1 antigens and OV1 for u 1Lom antigens) antiaera. 
The results are shown in Table 2.5. 
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Table 2.5 HomoloKous and heterologous antiserum titres 
obtained with 14os and T-140S antigens 
Strain Antigen Antiserum Antiserum titre 
l::xpt. 1 t:xpt. 2 ~xpt. 
OV1 140S OV1 3000 2632 291+1 
uV1 T-140S OV1 2182 1983 2308 
OV1 14os o 1Lom 523 402 459 
OV1 T-140S o1Lom 523 398 441 
o1Lom 140S 0 1Lom 1659 
o1Lom T-140S o1Lom 1364 
o 1Lom 140.S OV1 923 
u 1Lom T-140S UV1 882 
3 
From these results it can be seen that, whereas there was 
a significant decrease in the homologous antiserum titres 
(approximately 20;0 with T-140S antigens, the heterologous 
antiserum titres were virtually the same with 140S and T-140S 
antigens; i.e. the trypsin-treated antigen had a decreased sub-
type specificity. The slightly lower heterologous antiserum 
titres with T-140S antigen could be explained by a small degree 
of degradation of the antigen as referred to above in relation 
to 75S antigen. 
It would appear that tne antigenic site on VP1 which is 
affected by trJpsin has a high de~ree of sub-type specificity. 
4oweYer, it is notable that the titres of both antieera were 
much greater with homologous T-140S antigen than with the heter-
ologous antigen• i.e. that the T-140S antigen still possessed 
considerable sub-t ype specificity. Thie wo u ld suggest that the 
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trypsin-sensitive antigenic site is not the only one which is 
sub- t;yp e specific. 
2 ■ 3 ldJ ~he Type and 3ub-type Specificity of ~atural and 
Artificial 12~ AntiKens 
The final separation of natural 12S and VIA anti gens was 
carried out by sucrose density gradient centrifugation. Figure 
2.5 shows the profiles of complement-fixing activity of gradients 
used for the isolation of natural 12S anti gen (N12S) from the 
initial eluate of a DhAE-celluloae column ( Sample A) and t he 
isolation, of VIA anti gen from the fractions eluted from the 
column with a NaCl gradient (Sample B). The major peak from 
$ample A was used as N12S anti e en and th~ peak from sample b 
as VIA antigen. '£he identity of t nese antigens was confirmed 
on every occasion by heating a sample at 50°c for 30 minutes, 
which destroys VIA antigen (Cowan and Graves, 1966) but not 12S 
antigen. It is evident from Fi gure 2.5 that there was a certain 
amount o! VIA antigen in sample A. However, separation of the 
two peaks waa clear and so the N12S and VIA antigens were 
considered to be effectively separated from each other. 
Artificial 12S antigen (A12S), prepared by acid degradation 
of the virion and purified on sucrose density gradients, 
sedimented at the same rate as N12S antigen. Figure 2.6 shows 
the result of co-sedimenting a trace amount of 
14
c-labelled 
A12S anti~en, with N12S antigen detected by CF activity. 
Natural 12S antigens of the strains OV1 (t ype O), A6003 
(type A), RV 11/37 (type SAT 1) and ~V 7/34 (type $~T 3) were 
examined for type specificity in long-fixation Ci tests. The 
resul ta are anown in 'l'able 2 .6 • 
211 
121 
1 
.----. Sample A 
o-----◄ Sample 8 
3 s 7 
Fraction • 
11 
Top 
Figure 2.5. Comparison of the CF activities er fractions from 
aueroae density gradients for the preparation or natural 
12S antigen from Sample A and VIA antigen from Sample B. 
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Table 2.6 Relationshi~s between the natural 12S antif:iens 
of t;:z::ees o 1 Al :3AT 1 and SAT 3 
Strains !:.1 .!:2 R 
ov1, A600} 0.12 0.09 10;!6 
OV1, RV 11/37 0.02 0.02 2% 
OV1, RV 7/34 0.09 0.07 8% 
It is evident that heterotypic reactions occurred, but 
that they were very much lower than the homotypic reactions; 
i.e. the antigens possessed a very considerable degree of type 
specificity. The relationship between two straina of different 
European types (OV1 and A600}) was much cloeer than that between 
the type O and type SAT 1 strains (OV1 and RV 11/37), while that 
between type O and type SAT 3 strains (OV1 and RV 7/}l+) was 
intermediate, and not significantly different to that between 
the European strains. 
Natural 12S antigens of the type O strains, OV1 and 
o
1 
Lombardy and the type A strains, A6003 and A6900, were 
compared for sub-type specificity. The results of CF tests 
usinf:!; long and short fixation periods are shown in 'fable 2.7. 
•rable 2.7 Sub-tvne relationships between natural 12S antig•pp 
of t;i:nes 0 and A 
Strains Fixation 
period 
.£1 .£2 .R 
OV1, o 1Lom 
short 0.57 0.59 58~ 
OV1, o1Lom 
long 0.58 0.62 60% 
A6003, A6900 short o.46 o.46 4o'il, 
A6003, A6900 long 0.53 o.49 51% 
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It is evident that the natural 12S antigens possessed some 
sub-t ype specificity. The relationships shown in long-fixation 
tests were ~lmost identical to those in short-fixation tests 
indicating virtually no decrease in specificity of the reaction 
when the long fixation period is employed. 
Antiserum titres were considerably increased in long-
fixation, compared with short-fixation tests. In the homologous 
reactions of the teats summarised in Table 2.7, the antiserum 
titres were an averaLe of 5 . 4 times greater with long fixation. 
The homologous antiserum titres with natural 12S antigens 
were considerably lower than with 140S anti gens in both long 
and short fixation tests. Table 2.8 shows that the N12S 
antigen titres were generally three- to four-fold lower than 
the 1403 titres. 
Table 2.8 Homologous antiserum titre• to 14os and N12S 
antigens 
Strain Antigen Antiserum titre 
Short- Long-
fixation fixation 
OV1 140S }659 1}846 
OV1 N12S 116} 54}5 
o1Lom 140S 1786 
6207 
o1Lom N12S 588 
2841 
A600} 1406 596 }191 
A600} N12S 156 847 
A6900 140S 670 }168 
A6900 N12S 113 741 
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An antiserum prepared agai1st artificial purified UV1 12S 
antigen had titres against homologous N12~ antigen of 1/850 and 
against homologous 140S antigen of 1/248. Thie antigen was used 
in long-fixation CF tests against N12S antigens of the strains 
UV1 o1 Lombardy and A6003. 'rhe values for .!: obtained from these 
tests were: 
.!: (OV1/01Lom) = 0.55 
.!: (OV1/A6003) ~ 0.08 
These values were of a similar order to tnose obtained using 
the UV1 live-virus antiserum (values of 0.58 and 0.12 respectively). 
It is probable, therefore, that the presence of large amounts of 
anti-140S antibody in the live-virus antisera did not influence 
the results obtained to any large extent; i.e. that the 12S 
antigens were only reacting with 12S-specific antibody. 
An OV1 N12S antigen wae teated for potency in long and 
short fixation tests. The antigen activities obtained were: 
short-fixation 407 cfu., 
long-fixation 1709 cfu. 
Thus, the potency determined by long fixation was 4.2 times 
greater than with short fixation. 
A preparation of uV1 artificial 12S antigen was compared 
with natural 12S antigen of the same strain in a long-fixation 
CF test, by determining the antiserum titres of homologous, 
sub-type heterologoue (01 Lombardy) and type-heterologoue (A6003) 
antisera when teated with the two antigens• ~he results in 
~able 2.9 show that the naturally-occurring and the artificially-
produced antigens were almost identical, with the N12S antieen 
demonatrating alightly higher titres of all three antiaera. 
Table 2.9 Titres of uv1, o1Lom and A6003 antisera 1 tested 
with OV1 1 N12S and A12S antigens 
Antigen 
N12S 
A12S 
N12S 
A12S 
N12S 
A12S 
Antiserum 
OV1 
OV1 
A600} 
A600} 
Antiserum titre 
7656 
721+0 
3734 
3629 
60 
55 
2.3 (e) ~he TYDe and Sub-type Specificity of VIA Antigens 
Preparations of VIA antigen from the type 0 strains, 0V1 
and o
1 
Lombardy and the type A strain, A6003, were compared tor 
type and sub-type specificity. The 0V1 and o1 Lombardy antigens 
were tested in long and short-fixation tests (Table 2.10). 
Table 2.10 Sub-tyne relationships between VIA antigens of the 
strains OV1 and o, Lombardy 
Fixation period 
.£1 .£2 
(OV1 antiserum) (01Lom antiseru~) 
long (3 tests) 0.91 0.93 92"/4 
short {2 teats) 0.93 0.92 9~ 
It can be seen that the antigens were almost identical and 
that the same relationship { R • 9~, ) was obtained using both 
types of CF teat. The homologous antiserum titres in theee 
teats were greater in the long-fixation teats by a mean factor 
of 7.8 compared with those in abort-fixation teat•• 
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Table 2.9 Titres of UV1 1 o1Lom and A6003 antisera. tested 
witll OV1 1 N12S and A12S antigens 
Antigen 
N12S 
A12S 
N12S 
A12S 
N12S 
A12S 
Antiserum 
OV1 
OV1 
A6003 
A6003 
Antiserum titre 
7656 
7240 
3734 
3629 
60 
55 
2.3 (e) The Type and Sub-type Specificity of VIA Antigens 
Preparations of VXA antigen from the type O strains, OV1 
and o
1 
Lombardy and the type A strain, A6003, were compared for 
type and sub-type specificity. 'l'he OV1 and o1 Lombardy antigens 
were teated in long and short-fixation tests (Table 2.10). 
'!'able 2.10 Sub-type relationships between VIA antigens of the 
strains OV1 and o1 Lombardy 
Fixation period 
long (3 taste) 
short (2 teats) 
£.1 
(OV1 antiserum) 
0.91 
0.93 
E.2 
(01Lom antiserum) 
0.93 
0.92 
92% 
92'11> 
It can be seen that the antigens were almost identical and 
that the same relationship (R • 9~- ) waa obtained using both 
types of CF teat. The homologous antiserum titres in thee• 
teats were greater in the long-fixation teats by a mean factor 
ot 7.B compared with those in short-fixation teata. 
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Homologous antiserum titres to VIA antigens were much 
lower than those to either 140S or 12S antigens, as ie seen 
in Table 2.11. 
·rable 2.11 Homolo11:ous antiserum titres to 140S 1 12S and VIA 
antisens 
Strain Antigen Antiserum titre 
short- long-
fixation fixation 
OV1 140S 3659 13846 
OV1 N12S 1163 51+35 
OV1 VIA 124 878 
o1 Lom 140S 1786 
6207 
o1Lom N12S 588 
2841 
o 1Lom VIA 87 
729 
VIA antigens of the OV1 and A6003 strains were compared 
in a lon6-fixation test. The relationships obtained were: 
~, (OV1 antiserum) = o.87 
J:2 (A6003 antiserum) • 0.97 
~ -9~ 
Tbus it can be seen that VIA antigens derived from strains 
of two different types were virtually identical. 
2.4 UISCUSSION 
Tbe results of the experiment• presented in tnis Section 
have implications in regard to the structural relationships of 
the J:i'Ml) viral oapsid and antigenic component• derived from it. 
They also provide information which can be applied to the u■e of 
serological teats (in particular, CF) for typing and eub-typing 
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investigatione. 
It was found that the intact virion is antigenically 
completely type specific. Thie confirms the findings of Brown 
and Crick (1958) and Bradish and Brooksby (1900). However the 
method used for this work was more sensitive and could detect 
slight, spurious cross-reactions which ma) have been undetectable 
or mis-interpreted by other methods. Bradish and Brooksby (1960) 
obtained a low level of heterotypic fixation which they dis-
regarded. Talbot .!.L.!!• (1973) also demonstrated the type 
specificity of the 140S antigen. They centrifuged through 
sucrose density ~radiants, mixtures of 1251-labelled Fab 
fragments of the IgG molecule from FHDV antisera and homologous 
or heterologous virus. A peak of radioactivity, corresponding 
to the 1406 virue peak was obtained only with the homologous 
antigen. 
In contrast to the intact virion, 12S aub-units, both 
naturally-occurring and artificially-produced, are cross-reactive 
but still possess considerable type and sub-type specificity. 
This heterotypic activity was demonstrated by Brown and Crick 
(1958), and Bradish and Brookaby (1960) indicated that the 12S 
antigen had some type specificity. However the actual extent 
of the cross-reactions baa not been previously measured. 
It waa found tnat the relationship between the N12ti antigens 
of type■ O and A was closer than those b e tween type O and typea 
::lA'f 1 and S A'f 3. Thia ia possibly a aanifeatation of a closer 
relationship between viruses of the European types, than between 
the European and southern African typea, which ia likely, since 
the southern African type viruaea evolved in geographical 
ieolation from the European ones. However, this suggestion i• 
74 
made guardedly, since only a small number of cross-comparisons 
were made. 
It was demonstrated that natural and artificial 12S antigens 
had an almost identical reactivity with homologous, sub-type 
heterologous and type beterologous antisera. ~robably no 
conclusions can be drawn from the slight differences obtained, 
since the natural 12S antigens were not purified. They were 
considered to be free of 140S and VIA antigens, but may have 
contained other, as yet unidentified, viral antigens. 
The polypeptide, VP4, has been shown to react hetero-
typically (Talbot~-• 1973). However, since the artificially-
produced 12S antigen does not possess VP4 (Burroughs et al., 19714 
Strobmaier and Adam, 1974) 1 it is evident that there is more than 
one cross-reacting antigen present in the virus but that it is 
not reactive when the capsid is intact. 
The results of experiments with empty capeids, indicate 
that they have identical serological specificity to complete 
virions and this would suggest that the capsid structure of the 
two kinds of particle is antigenically identical. There are, 
however, other differences between the particles. As already 
noted, empty capsids are acid-resistant, SDS-sensitive and 
relatively unstable. Furthermore, Talbot (1972) demonstrated 
that empty capaids differed from co~plete virione in the poly-
peptide composition shown by polyacrylamide gel electrophoresis. 
'l'he HNA-free particles possessed VPv which was interpreted aa 
being a complex of VP2 and VP4 since, with ageing, the proportion 
of VPO decreased and that of VP2 and VP4 increased. Strohmaier 
and Adam (1974) on the other band, using different conditions 
for electrophoresis, found that VPv was normally not detected 
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and VP4 was never foun d in empty capsids. Thus the exact 
nature of the polypeptide differences is not resolved, but it 
seems reasonable to assume that the capsid structure of the 
two particles is essentially identical, with minor differences 
affecting the manner in which they are dissociated under 
denaturing conditions. 
Graves et al. (1968) suggested that empty capeids differed 
antigenically from complete virions, in reacting with anti-12S 
serum in agar gel diffusion tests. However, in the light of 
the present evidence of antigenic identity, it is suggested 
that the difference found by Graves et al. was due to partial 
degradation of the less stable empty capsids, exposing antigenic 
sites which in the intact capsids of full or empty particles are 
not reactive. 
The present findings differ from comparisons made between 
empty and complete virions of other picornaviruses. Roizman 
~- (1958) showed that poliovirus empty capsids consist of 
a heterogeneous population, some having the same serological 
reactivity as infectious particles and others being unrelated. 
Other workers with poliovirus (Scharff li..!!•• 1964; Ghendon 
and Yakobson, 1971) and with other enteroviruses (Frommhagen, 
1965a Forsgren, 1969) have found that complete and empty capsida 
are serologically unrelated. Lonberg-rlolm and Yin (197}) 
studied complete and empty capside of human rhinoviruses. They 
found that the particles posse■sed some, but not all of their 
antigens in common. It is possible that the lack of a closer 
antigenic relationship is the result of relatively minor 
structural or conformational modifications in the empty capsida 
of th••• enteroviru■es which, after all, probably contain the 
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same protein sub-units as the complete virione . Thus the 
contradictory findinGs between enteroviruses and FMDV, do not 
necessarily represent a major differenc€ in the structural 
relationships of the viral antigens within these two groups. 
It hae been shown previously by other workers (Rowlands 
~-• 1971), that trypsin-treated virus has a greatly reduced 
immunogenicity but t hat it never-the-less produces significant 
amounts of neutralising antibody. Brown and Smale (1970) have 
suggested that the effect of the enzyme is to destroy an anti-
genic site normally present at regular intervals on the surface 
of the virion, probably at the icosahedral vertices. 
It has been demonstrated in the present work that this 
antigenic site is highly sub-type specific, since its destruction 
reduces the homologous antiserum titre but not that of the sub-
type heterologous antiserum, when tested •~•inst the antigen. 
This is consistent with previous findings, since it is reasonable 
to expect that an antigenic site so important for the immuno-
genicity of the virus would be highly specific. 
However, it was also shown that trypsin-treatment only 
reduced, but did not destroy, the sub-type specific identity 
of the antigen and this was with supporting evidence that the 
treated antigen was quantitatively converted to the altered 
form. Thie provides convincing evidence that there is more than 
one sub-type specific antigenic site on the surface of the 
virion. Since intact virions cross-react between sub-types, 
there must be at least one other type of surface antigen which 
ie not sub-type specific. Coneequentl) from these experiments 
with trypain-treated virus, one can draw the aame general 
conclusion as Brown and Smale (1970)1 ,W• that there appear 
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to be at least three types of antigenic site on the surface of 
the virus. 
It has been shown that the most cross-reactive antigen in 
an FMUV harvest is the VIA antigen. which has virtually no type 
or sub-type specificity. The 12S antigen. although cross-
reactive. possesses a considerable degree of specificity. Cowan 
and '£rautman ( 1967) sug p;ested that VI A antigen was the main 
cause of cross-reactions encountered in diagnostic CF typing 
tests and the present work supports this. Consequently a 
diagnostic CF method for the typing of field strai n s should be 
designed to be minimally influenced by VIA antigen in particular 
and also by 12S antigen. 
The CF test currently in use in the ,1orld Reference Laboratory 
for the detection and type differentiation of FkDV in field 
samples, inYol••• the testine of a ei ngle concentration of the 
unknown antigen against serial dilutions of antieera of each of 
the seven FMDV types, with a fixed dose (5C 1 H50 ) of complement. 
The test is performed in microplatee, with primary fixation 
proceding for 30 minutes at 37°c. The antisera are prepared by 
the method of Brooksby (1952) (Appendix 3). A number of 
criticisms can be made of the method and several modificationa 
are proposed. 
The diagnoetic test should be sensitive in detecting FM V 
antigen and selective for type differentiation. The use of a 
very short Cixation test is of relatively low sensitivity and 
the use of low dilution• of both anti g ens and antiaera pre• 
disposes to the detection of crose-reactione. The reaction due 
to VIA antigen, probably the mo•t important cross-reaction, is 
al•o the easie•t to exclude. Antieerum produced aeainst in-
activated purified 140S antigen does not contain anti-VIA 
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antibody (Cowan and Graves, 1966). Therefore, the use of such 
sntisera would entirely eliminate VIA cross-reactions. 
It ie more difficult to avoid cross-re~ctions due to 12a 
antigen since anti-140S antisera always possess some anti-12S 
activity (Cowan, 1968; personal uncited reeults). However, the 
homotypic 140S titre of an anti-140S serum should be much 
greater than the titre to heterotypic 12S antigen. Modification 
of the test method, to a constant antiserum, varying antigen 
method, may enable the selection of fixed concentrations of 
antisera of suitable quality, such that homotypic 140S antigens 
react with exceee antibody but that antibody to heterologoue 12S 
antigen is present in minimal amounts, perhaps undetectable. 
For example, the 0V1 live-virus antiserum used in long fixation 
teats had a titre of 1/13~00 to homologous 140S antigen. The 
titre for homologous 12S antigen was 3-fold lower and to hetero-
typic 125 antigens at least 30-fold lower (type A). Therefore, 
this antiserum could be used at 8 or 16 times the homologous 
140s titre and would still not detect heterotypic 12S antigens. 
Such a test would have the added advantage of being quantitative, 
the results being expressed as antigen titres. Results of the 
currently used teat, expressed as antiserum titres are quantit-
atively quite meaninglesa. 
with regard to increasing the senaitivity of the teat for 
antigen detection, it has been shown in this Section that 140S 
and 128 antigen titres are increaeed approximately four-fold 
0 
using a fixation period of 18 hour• at 4 C compared with abort-
fixation (30 minute• at 3?°C in tubes, which ia equivalent to 
60 minutes at 37°c in microplatea). Conaequently, the use of 
overnight fixation at 4°c would be expected to increaae the 
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sensitivity of the test by more than four-fold. 
Bradish and Brooksby (1 960) showed that FM UV antigens 
cross-reacted between types to a g reater extent with long 
fixation. The present studies of cross-reactions between sub-
t ypes suggest that the cross-reactivity of individual antigens 
does not increase markedly with lone fixation. However, while 
the homologous antiserum titres to 140$ and 12S antigens were 
approximately four times greater in long-fixation tests, the 
antiserum titres to VIA antigens increased eight-fold. 
Consequently, the marked degree of increased cross-reactivity 
observed by Bradish and Brooksby (1960), was possibly due to a 
more selective measurement of VIA antigen. It follows from the 
present results that the use of a long-fixation test, if performed 
with the other modifications proposed to minimise cross-reactions, 
would increase the sensitivity without markedly decreasing the 
specificity of the test. 
It is also possible to make certain observations regarding 
the procedure for sub-type differentiation. It was demonstrated 
that 140s, 12S and VIA antigens have different sub-type specifi-
cities, the 140S antigen being the most specific. In contra-
distinction to type diCferentiation, which requires sensitivity 
of anti g en detection and type but not sub-type specificity, for 
sub-type diCferentiation the most important requirement is for 
specificity or the reaction, so that only the 140S anti gen/ 
antibody reaction is being measured. 
In Section 1, it was shown that CF teat• for sub-type 
difr•rentiation u••d by many earlier workers were quantitatively 
invalid. lt ia aleo probable tnat the use ot a test with a 
constant oonoentration (in •o-called exce••> or crude antig•n 
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means that cross-react io ns are being measured between the three 
complement-fixing antigens, to an extent depending on their 
relative concentrations and the relative concentrations of 
their antibodies in the antieera. 
It is evident from results given in this Section and also 
from the results of Cowan and Trautman (1967), that antisera 
produced in guinea pigs usin e live virus as anti gen, are moat 
reactive with 140S antigen, less so with 12S antigen and even 
less with VIA anti gen. Consequently, the method developed in 
Section 1 for sub-type differentiation, being baaed on dilution 
of the antisera to their end-points, will tend to measure the 
140S reaction in preference to the others. The use of purified 
140S antigen will ensure that there is no VIA antigen and little 
125 antigen present, although a certain degree of breakdown of 
the 140S antigen is inevitable. The evidence from tests using 
12S-adsorbed antisera, with which sub-type specificity was the 
same as with unadsorbed antisera, suggests that with the 
procedure used for these tests, only the reaction of 140S antigen 
was being ■eaaured . Further evidence for this is provide d in 
Section 3, from tne results or cross-protection tests and kinetic 
serum neutralisation tests. 
#hen the CV1 and o1 Lombardy strains were compared for sub-
type specificity using anti-140s sera, the result■ were very 
similar to those obtained with live-virus antisera. Difference■ 
-y be attributable to different aviditie• of the antisera and 
this asp•ct i• diecueeed further in ~action }.4. 
It ha■ been shown preYiously (Hradish and Hrooksby, 19b0) 
and confirmed in thie study, that the reaction with 140S antigen 
ia more apeci~io in a short-fixation than in a long-fixation t eat . 
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Therefore it ie an advantag e to use a short-fixation period (30 
minutes at 37°C in tubes or 60 minutes at 37°c in microplates ) 
for greater sensitivity in sub-t yp e different i ation. 
2.5 CONCLUSIONS 
The intact virion has the greatest sub-type specificity of 
the rMDV antigens and cross-reactions between sub-types are lees 
evident in short-fixation tests. Fresh preparations of tnis 
antigen have no heterotypic reactivity. 
123 sub-units, both naturally-occurring and artificially-
produced are cross-reactive but still possess considerable type 
and sub-type specificity. In contrast, the non-structural virus 
infection-associated antigen is almost completely non-specific 
with regard to type and to sub-type. 
Empty capsida appear to have a sub-type specificity and 
antigenic potency identical to that of intact virions. Trypsin-
treated 140S antibens had a reduced reactivity with their homo-
logous antisera and a lower sub-type specificity. This verified 
that the polypeptide, VP1, which is altered by the action of 
trypsin, is associated with a highly specific antigenic site. 
A number of recommendations were made, for the type identi-
fication of field i•olates of FMDV by CF. Teets should be 
carried out with a long fixation period for maximum sensitivity 
of antigen detection. Antisera should be prepared against 
inactivated antigens, to eliminate cross-reactions due to the 
presence of VIA antigen. A titration of the unknown anti gen 
against constant concentrations of known antisera, would provide 
a quantitative result. 
It was verified that the method proposed in Seotion 1 tor 
the •ub-type differentiation of FMDV •train• is a auitable 
method for the detection of strain differences. The use of a 
short-fixation test and the determination of antiserum end-
points favours the measurement of the 140ti reaction. 
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S.I::CTivN 3. AN EVALUA'U ON <.JF TliE SIGNH ' ICANCE C.F .FMDV STRAIN 
DIFFERENTI AT ION BY CuMPLtMtNT-Fl XATI ON 
~.1 INT RO~UCTION 
The detection of antigenic differences between FMDV strains 
within a type has received considerable attention because of its 
importance in the field, especially in relation to the ident-
ification of new strains and the selection of vaccine strains. 
From t his aspect, the final criterion for the differentiation of 
two strains should be their performance in cross-protection 
tests in livestock. However, such tests are likely to be 
prohibitively expensive and other methods have been sought. CF 
has become the moat widely applied technique for strain differ-
entiation but, for its application to be valid, it must have a 
reasonable correlation with differences determined by cross-
protection. 
Traub and M~hlmann (1946) showed that strains which could be 
differentiated by CF were also immunogenically different, in 
that groups of cattle vaccinated with one strain withstood homo-
logous challeng e but were only partially protected a gainst 
challenge with a heterologoue strain. Similar qualitative results 
were also obtained by a number of other workers (Henderson!..!.....!!.•• 
1948; V.artin .tl...!l•• 1962; Hyslop~-• 1963; Hedger and 
Herniman, 19~6). Several of them (Brooksby et al . 1948 a & b; 
Hyslop~• 1~63; Hedger ane Herniman, 1966 ) have shown that 
antigenic di~ferences detected by CF and by cross-protection 
tests can also be demonstrated by cross-serum neutralisation 
tests. 
~uantitative cross-protection tests have also been devised, 
based on the determination or heterologous and homologous 50',\. 
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protective dose (~~50 ) values. Kuntiu (1~65) described the use 
of such a test in cattle and found that the difference obtained 
between two strains was similar to that determined by CF. 
Fontaine et al. (1966) developed a similar cross-protection 
test for FMDV strain differentiation using guinea pigs and this 
method has been used by other workers ( Moosbrugger tl...!!• 1967; 
Tekerlekov, 1~7}). However, there is very little comparative 
evidence by which to assess the si gnificance of differences 
detected by serological tests in terms of the susceptibility of 
vaccinated animals to challenge by heterologous strains in the 
field. 
In this Section are described comparative tests carried out 
with two FMDV strains to demonstrate differences by complement-
fixation, by kinetic serum neutralisation tes ts, by conventional 
cross-neutralisation tests and by a guinea pi g cross-protection 
test. 
The antigenic differentiation of strains by CF has been used 
as the basis for the classification of strains within a type into 
sub-type groups. Such a classification should demonstrate the 
range of antic;enic variation that occurs withii, a type and should 
simplify the procedure for the identification of new strains. 
If all known strains can be placed in sub-type groups, then a 
small number of comparisons with an unknown strain ahould enable 
one to classify the new strain and so obtain some indication of 
its relationship to all other strains. 
The term "sub-type" has ne•er been precieely defined. 
Brooksby ( 1968) proposed it as follows, "A aub-type can then 
be defined ae a group o! strains which can be differentiated 
from other groups o! etraine within the type by serological 
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methods or by cross immunity experiments at a level of immunity 
lower than that possessed by recently recovered animals - 1or 
example, in vaccinate d animals." The implication is that 
animals vaccinated with one strain would be protected a ga inst 
challenge wit h another strain of the same sub-type, but not of 
a different sub-type. Brooksb y (1968 ) suggested the following 
values for~ (as defined in Section 1.2) for type and sub-type 
differentiation by CF: 
(1) type difference !! = 10"/4 or lower 
(2) sub-type widely different R = 1~ - 3 2% 
(3) sub-types different !! 32% - 70,o 
(4) differences within sub-type !! = 70'tv - 100% 
Following these criteria, the Norld Reference Laboratory at 
Pirbright has classified strains of each type into a large 
number of sub-type grou ps - from 3 sub-types within the Asia 1 
type to 32 sub-types within type A. 
If the genetic alteration involved in the formation of a 
new sub-type occurred as a single mutation which was readily 
detectable antigenically, then sub-type classification would be 
straightforward with each strain falling into one or another 
group. However, if the alteration was the result of a number 
of small antigenic changes, then there would be no natural 
separation into groups and the selection of sub-type limits 
must be somewhat arbitrary. The selection of such limit• i• 
reasonable if it is useful. To cla•e i fy all •tra ins a• one 
sub-type or, alterna tively, to classify every antigenic variant 
as a new sub-type would be of little benefit. Consequently, it 
is important to determine both the character and the ran~• of 
ant i~enic yariation within a type, to satisfactorily claaeify 
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strains. In this Section, the results are presented of a large 
number of cross-CF tests carried out between strains of one 
type , to obtain an indication of the anti genic variation 
encountered within a type. 0n the basis of these results, new 
criteria are proposed for the classification of sub-types of FMDV . 
3.2 1'1ATERIAL.:i AJ;D M,.,;THODS 
3 .2 (a) The Guinea P ig ~rotection Test 
Viruses were grown on BHK monolayers, inactivated with AEI 
and purified by sucrose density gradient centrifugation all as 
described in Appendices 2 (a) and (b). The gradient fractions 
containing the peaks of 140.:i activity were identified by er assay 
(Appendix 4). The quantity of virus present in each peak fraction 
was estimated by measuring the OD of the sample at 259 nm. and 
calculating the concentration of virus on the basis of the 
finding of Bachrach~• (1964) that 1 OD unit= 132.)l&•/ml. 
of purified virus. 
Vaccines were prepared in three-fold dilution series by 
suitably diluting the virus in o.04M phosphate buffer at pH 7.6, 
containing 0.1~ bovine albumin powder and o.01~ saponin. Guinea 
pigs of approximately 600 g. bodyweight were inoculated sub-
cutaneously with a 1 ml. dose of vaccine, on the aay following 
the purification of the viruses. For each dilution of each 
vaccine, groups of eight guinea pigs were inoculated for homol-
ogous or heterologous challenge. 
Viruses for the challenge of vaccinated guinea pigs were 
prepared as described in Appendix 2 (a) and titrated for infect-
ivity b1 inoculation of virus in 10-fold dilution aeries from 
the guinea pig adapted stock virus. 0.1 ml. of each dilution 
was inoculated intradermally into one tarsal pad of each of fi•e 
guinea pigs. The animals were examined daily for seven days and 
where specific lesions of FMD were observed at sites other than 
the inoculation site, a positive result was recorded. The 
infectivity of the stock viruses was then calculated by the 
method of Kirber (1931). 
At 28 days after vaccination, groups of guinea pigs were 
challenged with the homologous or heterologous virus by inoculating 
them with an estimated 102 • 0 guinea pig 50% infective doses 
(GPID50 ) in the same manner as for the challenge virus titrations 
and positive reactions were assessed by the same criteria. The 
challenge viruses were re-titrated at the same time. 
From the results of the test, the 50)!, protective dose (PD50 ) 
was calculated for each v~ccine for homologous and heterologous 
challenge by the method of Heed and Meunch (1938). 
A value for£ was determined for each vaccine, being the 
proportion PD50 (homologous)/PD50 (heterologous). From values of 
£1 and £2 for the two vaccines, the cross-protection relationship, 
~ (C~), was determined for the two viruses in a manner analogous 
to that described in ciection 1.2 for the CF test. 
At 21 days after vaccination, blood samples were taken from 
every animal by cardiac puncture. Assays for serum neutralising 
antibody activity were carried out in microplates as described in 
Appendix 8. Sera from all eui.Deapigs vaccinated with tne same 
strain of virus were assayed in the same test. They were diluted 
in the plates from a starting dilution of 1/4 and were tested 
against an estimated 101 • 5 TCID of homologous virus per well. 50 
312 (b) The ~inatic NeutrAlisation Test 
Kinetic neutralisation test8 were performed by mixing virus 
and antiserum and taking samples 1 at fixed time intervals, wbicb 
B8 
were immediately diluted and subsequently titrated for plaque 
production in tissue culture. 
The diluent used was phosphate-buffered saline, pH 7.4, 
with 0.1~ bovine albumin powder ( PBciA). The BHK adapted, 
g lycerinated viruses (Appendix 2 (a)) were diluted to an infect-
ivity of between 3 x 105 and 8 x 105 pfu./ml. Guinea p i g antisera 
were inactivated at 5b°C for 30 minutes and diluted to a pre-
dete r mined concentration which would give a suitable rate of 
neutralisation. 
Neutralisation was carried out at room temperature. Two 
viruses were tested a Eainst one antiserum in the same test. One 
ml. of virus was added to 1 ml. of PBSA (to determine the initial 
infectivity) or to 1 ml. of antiserum. Samples of 0.25 ml. were 
taken from the virus/antiserum mixtures at fixed intervals and 
mixed with 24 ml. of diluent at o0 c. '1'hree-fold dilutions were 
then made from these and each dilution used to inoculate three 
lB-RS-2 monolayers in Petri plates (Appendix 6). After incubation, 
fixing and staining (Appendix6 ), plaques were counted and the 
mean titre for each sample was determined from a weighted mean 
of dilutions producing between 10 and 100 plaques on each plate. 
For each virus/antiserum mixture, the rate of neutralisation 
was determined by the method of least squares, fro m the infect-
ivity titres of individual samples. A neutralisation constant 
(K) was then determined usine the equation1 
K • ll/t x 2.3 log10 Vo/Vt, 
where D. reciprocal of the antiserum dilution, 
t • time in minutes and 
Vo and Vt represent the infectivity of the mixture at 
times o and t respectively. Using the values of K for homologous 
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and heteroloeous reactions obtained in the same test, values for 
£ were determined for each antiserum, being the proportion K 
( heterologous )/K (homologous) . Ji t h va l ues o f £ 1 and £z for 
the two antisera, the kinetic neutralisation relationship, E (KN) , 
was determined for the two viruses as previously described 
(Section 1.2). 
3.2 (c) The Conventional Cross Serum Neutralisation Test 
Croes-serum neutralisation tests were carried out in micro-
plates. The reagents used and the conditi ons are described in 
Appendix 8. 
To compare two strains, each antiserum was diluted in two-
fold intervals and titrated in eight replicate s aeainst two 
concentrations each of homologous and heterologous viruses, 
estimated to be 101 •5 and 102 • 5 TC ID per well. Antiserum 50 
titres for each concentration of each challenge virus were 
determined from the test and the titre of each antiserum a gainst 
102 • 0 TCI D of each virus was determined by graphical inter-50 
polation between the titres for the two challenge doses. Values 
of L for each antiserum were determined as the proportion of -
titre with heterolo~ous virus. From values for £ 1 and £ 2 a 
titre with homologous virus 
value for the cross-neutralisation relationship, ~(CN), was 
determined as described in Section 1.2. 
3 .2 (d, Complement-fixation Tests in Hicroplates for Sub-type 
Differentiation 
The differentiation of strains by CF was carried out using 
the principles developed in Section 1. However, a number of 
modifications were maae to enable a lare e number of teats to be 
carried out on a routiue basis. 
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Unless otherwise stated, the antigens used were BHK mono-
layer harvests, concentrated and partially purified by pelleting 
as described in Appendix 2 (b), but without the final purification 
step of sucrose density gradient centrifugation. These are 
referred to as pelleted 140s antigens. Anti gens were stored at 
-70°c, diluted in VHS. 'l.'he results of many tests with antigens 
used before and after storago , indicated that there was no 
significant alteration to the antigens on storage for up to three 
months. 
Guinea pi g antisera were prepared by two methods. Live-
virua antiserum was prepared using guinea pig adapted virus ae 
described by Brooksby (1952) (Appendix 3 (a)). 140S antiserum 
was prepared using purified, inactivated 140S antiben as 
described in Appendix 3 (c). The latter method enabled antieera 
to be prepared in a shorter time and without the need for high 
security animal accommodation. 
~he cross-CF tests were carried out in microplatea as 
described in Section 1.2. 
3- 3 RESULTS 
3.3 (a) The Guinea Pig Protection Teat 
The two type A strains, A6003 and A6900, previously compared 
by CF (Section 1.3 (b)) were compared in a guinea pig cross-
protection test. ~urified, inactivated 14DS antigen of the two 
strains contained 300 pg./ml. (strain A6003) and 250 p g ./ml. 
(strain A6900) of virus in the peak fractions of the preparative 
sucrose density gradients. 
Guinea pigs were challenged 28 days after vaccination with 
an estimated 102 • 0 GPID50 of either the homolo~oua or the heter-
ologous vi.rue. 'l'h• actual inf'ectivity titrea of the two challenge 
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viruses, from titrstions at the time of challenge were 101 • ~ 
( A6003) and 102 " 1 (A6 900) GPI D50 • The results are shown in 
Table 3.1. 
From the PD50 values, t he values for£ and j (C~ ) were 
calculated and are as follows: 
,!:1 (vaccine A6003) = 0. 53 
~ {vaccine A6900) = 0.36 
B_{CP) = 3~ 
The results of titrations for neutralising antibody in sera 
obtained at 21 days after vaccination are shown in Table 3.2. It 
is evident that the antibody titres were very low and in fact, 
around the level of 1 PD50 (homologous) for each vaccine, anti-
body was generally not detectable. However, the method of anti-
body titration is considered to be relatively sensitive. For 
comparison, reference antisera were titrated in the same tests, 
being those used for the CF tests in Section 1.3 {b). Their 
8 ntibody titres were 1/4096 (A6003) and 1/3388 (A6900). 
Although serum antibody levels were mainly undetectable for 
vaccine doses around the minimum for homologous and heterologous 
protection, the mean antibody titres for g roups of guinea pig s 
vaccinated with larger doses of antigen suggest that there was a 
decrease in antibody titre of the order of two-fold for each 
three-fold decrease in antigen dos • I f it ia aaau■ed that a 
relationship of a similar order would hold for smaller vaccine 
doses around the 1 PD50 level, then it can be argued that for 
these two strains, heterologous protection requir es about twice 
the concentration of circulating antibody needed for homologous 
protection. 
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'fable 3.1. Hesults of homologous and heterolo~ous challen~e 
of ~uinea Pi~s vaccinated with purified 140G antie;en of r,-w V 
strains A6002 and A6'300 
Challen ge Vaccine Anti c;e n Proportio n of Value of 
virus strain virus strain dose ( ng ) positive Pi.>50 (ne;) 
reactions 
A6003 Ao003 1,111 o/8 33 
370 0/8 
123 0/b 
41 3/8 
14 7/7 
A6900 A6003 10,000 0/8 99 
3,333 0/8 
1,111 0/8 
370 0/8 
123 3/8 
41 8/8 
14 7/8 
A6';100 A6900 1,111 0/8 90 
370 0/8 
123 4/7 
41 5/8 
14 8/8 
A6003 A6900 10,000 0/7 258 
3,333 o/8 
1,111 0/8 
370 2/8 
123 7/7 
41 7/8 
14 8/8 
Table 3 ■ 2 ~eutralisinu antibody titres of sera from guinea 
ni,.s 21 days after vaccination with purified virus vaccines of 
the strains A6003 and A6900 
Vaccine 
virus strain 
A6003 
A6900 
Antigen 
dose (ng) 
10,000 
3,333 
1,111 
370 
123 
41 
14 
10,000 
3,333 
1,111 
370 
123 
41 
14 
Neutralising 
antibody titres 
Range Mean 
32-128 
16-45 
11-45 
4-45 
<4-16 
< 4-8 
<4-4 
32-128 
45-128 
11 -181 
8-64 
<4-4 
94 
69 
30 
25 
11 
59 
76 
36 
18 
Proportion with 
positive titres 
8/8 
8/8 
16/16 
16/16 
7/15 
2/16 
1/15 
8/8 
8/8 
16/16 
15/15 
8/15 
2/15 
1/15 
3 - '5 ( b) 'rhe Kinetic Neutralisation Test 
Kinet i c neutralisation tests were c a rried out with the two 
t ype~ strains, Ab00 3 and A6900, which had b e en compared by CF 
( Section 1.3 (b J) and b y cross-protection in guinea p i gs {Section 
3.3 (a)). The antisera were t hose used for the CF tests in 
S ection 1.3 (b). 
Preliminary experiments were carried out to verify that the 
rate of neutralisation in this system is determined by the 
principles elucidated by Dulbecco ~• (1 965 ), on which the 
validity of t h e formu l a used for the calculation of h-values is 
dependent. 
An experiment carried out witn A6900 virus and antiserum 
showed that with a virus concentration of approximately 3 x 10
5 
p fu./ml. and antiserum diluted 1/1 000, the reaction appeared to 
be of the first order for a period of about 10 minutes (Figure 
3.1). To ensure that neutralisation was being measured during 
the period of first order reaction, subsequent experiments were 
carried out over four minutes, taking samples at one minute 
intervals. 
h further experiment with A6900 virus and antiserum (Figure 
3.2) demonstrated that the first order character of the reaction 
was independent of antiserum concentration. The values of~ for 
the three antiserum dilutions were: 
antiserum 1/1600, K • 276; 
antiserum 1/800, K = 350; 
antiserum 1/400 , K • 299• 
these values determined for K can be considered the same (within 
experimental error) and this indicates that the value or K is 
independent of the antiserum concentration. Consequently the 
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rate of neutralisation was proportional to the concentration of 
antiserum. 
rhree experiments were then performe d with both of the 
antisera, A6003 and A6900 , to measure the values of K for 
homologous and heterologous reactions and fro m the s e to determine 
values for.!: and .Ji(KN). li'igure 3.3 shows the results of typical 
experiments with each antiserum. The values of Kand L• determined 
from the experiments, are presented in Table 3.3. 
Tab.le 3.3 Values for K and r, determined by kinetic 
neutralisation tests with the strains A6003 and A6900 
Antiserum Expt. No. K (homologous) K {heterologous) I. 
A6003 1 171 49.6 0.29 
A6003 2 154 70.7 o.46 
A6003 3 152 53.5 0.35 
A6003 4 124 50.0 o.4o 
A6900 1 161 94.3 0.59 
A6900 2 271 161 0.59 
A6900 3 219 117 0.53 
It is apparent from Table 3.3 that although individua1 K 
values were highly variable, the values of I, were rather less so 
{the maximum range of variation was! 25"~ of the mean value). 
From the values for L• mean values for .£1 , .r.2 and !(KN) were 
obtained as follows1 
.1:1 {antiserum A6003) • 0.37 
1:e (antiserum A6900) • 0.56 
ji(KN) • 46% 
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rate of neutralisation was proportional to the concentration of 
antiserum. 
Three experiments were then performed with both of the 
antisera, A6003 and A6900, to measure the values of K for 
homologous and heterologous reactions and from these to determine 
values for£ and !(KN). Figure 3.3 shows the results of typical 
experiments with each antiserum. The values of Kand£, determined 
from the experiments, are presented in Table 3.3. 
'l'ab.le 3. 3 Values for K and r, determined by kinetic 
neutralisation tests with the strains A6003 and A6900 
Antiserum Expt ■ No. K (homologouis) K (heterologous) 
A600} 1 171 49.6 
A600} 2 154 70.7 
A6003 3 152 53 ■ 5 
A6003 4 124 50.0 
A6900 1 161 94.3 
A6900 2 271 161 
A6900 3 219 117 
a: 
0.29 
o.46 
0.35 
o.4o 
0.59 
0.59 
0.53 
It ie apparent from Table 3 ■ 3 that although individual K 
values were highly variable, the values of~ were rather lees eo 
(the maximum range of variation was~ 25"/4 of the mean value). 
From the valuee for L• mean values for L11 Lz and i(KN) were 
obtained ae followe1 
(antiserum A6003) • 0.37 
(antiserum A6900) • 0.56 
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,.3 (c) The Conventional Cross Serum Neutralisation Test 
Cross serum neutralisation tests were carried out with the 
strains Ab003 and A6900. Viruses and antisera were the same as 
those used for the kinetic neutralisation teats. Two tests were 
carried out and the results are shown in Table 3.4. 
Table 3.4 Cross serum neutralisation tests with strains 
A6003 and A6900 
Expt. No. Antiserum Antiserum titre 
homolo gous heterologous 
1 
2 
A6003 
A6900 
A6003 
A6900 
1202 
3236 
1479 
2427 
513 
851 
The mean values !rom Table 3.4 are: 
1:1 (A6003) antiserum= 0.36 
.£2 (A6900) antiserum~ 0.27 
B,(CN) • 32% 
.!:. 
o.43 
0.26 
0.31 
0.29 
B,(C N) 
5 ■ 3 ld) Cro~s-CF Tests with Strains of FMDV Type JAT 1 
Cross-CF tests were carried out with 16 strains of type 
~AT 1 FMDV. It was desired to investie;ate tne ranee anri the 
pattern of variation between strains, in order to evaluate the 
validity of criteria used for sub-type classification. ~he 
strains included one of each sub-type as classified by the ~orld 
rteference Laboratory and a number of recent field isolates from 
~est, East and Southern African countries. 
Some antieera were obtained from the World Reference Labor-
atory and had been prepared by tne method or Brooksby (1952) 
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(live-virus antisera). Others were prepare d a ~ainet purified, 
inactivated 140S antigens (140~ antisera). Unles s oth erwise 
specified, the antisera used were as follows: 
?.V 11/37 ( Rhodesia, 1937), 140S 
SWA 1/49 (South West Africa, 1949), live virus 
SR 2/58 (Southern Rhodesia, 1958), live virus 
SA 13/61 (South Africa, 1961) 1 live virus 
S II A 40/61 (South J est Africa, 1961), live virus 
TU R 323/62 (Turkey, 19b2) 1 140S 
GHA 1li/68 (Ghana, 1968), live virus 
BVl' 1/68 (Botswana, 1968), 140S 
MAL 3/70 (Malawi, 1970), 140S 
UGA 47/71 (Uganda, 1971), 1405 
KEN 3/72 (Kenya, 1972), 140S 
RHO 4/72 (~hodesis, 1972), 140S 
ANG 9/72 (Angola, 1972), 140S 
NIG 9/72 (Nigeria, 1972), 140S 
GHA 7/73 (Ghana, 19?3), 140S 
.. AM 25/?3 { ~ambia, 1973), 140S 
The first six strains above, represent the six sub-types 
currently recognised by the World Referenc e Laboratory. 
The results of the tests are summarised in Table 3.5. The 
values for .!i represent geometric mean values of at least two 
tests. If individual values for£ between two strains differed 
by two-fold or more, further teats were carried out. 
The range of values of j shown in the Table is lar5e and 
suggests a continuous gradation fro m virtual identity(~~) to 
~ or less. There is no clear pattern of variation, in that 
strain• which are furthest apart in time of isolation are not 
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Ta b l e 3 ■ 5 Values fo r H (~ ) dete rmined by cros s - CF be tween 
strains o f l'MIN t ype SAT 1 
I 3c ~V1 1/37 
S'wA 1/ 4 
2? 16 23 9 3 14 4 10 15 (3 
9 23 35 32 21 7 
2/58 27 55 32 14 
s.i. 13/61 42 24 10 21 23 10 
SwA40/61 32 t 6 
TU R323/62 22 33 21 30 43 23 11 
GHA 14/68 4 5 f3 
BlJT1/68 28 31 30 16 7 
M1,L3/70 18 96 16 13 
UGA47/71 14 
KEN3/72 
,mu4/72 11 
A,lG9/72 
NIG9/72 
11 
GHA7/73 
9 19 
18 25 
10 10 
5 (3 
7 15 
4 25 
3 
12 23 
2 4 
65 
3 
-
ZAM25/73 
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necessarily those showing the g reatest differences. Also there 
is no indication that t he strains can be readil y classified into 
groups of related strains ■ This problem is discussed at leng th 
in Section 3.4 (b). 
Since the antisera used were prepared by two different 
methods, it was coneidered nece s sary to make eome comparison of 
their quality. Live-virus and 140S antisera Cf the strains 
KV 11/37 anu BLT 1/68 were tested a 6ainst pelleted anti ~ens, 
purified 1405 anti gens and 12S antigens (prepared by heating 
purified 140S anti gen at 56°c for 30 minutes). Table 3. 6 shows 
the results of cross-CF tests and in Table 3 ■ 7, antiserum titres 
to homologous 1405 and 125 antigens are shown. All results 
represent mean values from at least two tests. 
It is evident from Table 3.6, that the values determined 
for~ and .!i were similar with pelleted or purified 1405 antigene 
but different with 12S antigens ■ This suggeets that the pelleted 
antigens were of good quality; i.e. that they consisted mainly 
of 1405 antigen ■ However, the values determined with either 
pelleted or purified 1405 antigens were very different, depending 
on the type of antisera used ■ The homologous titres (Table 3.7) 
of three of the four antisera were greater with 140S than with 
12S antigens. However, for the BUT 1/6b live-virus antiserum, 
the anti-12S titre was greater than the anti-140S titre. The 
relative anti-12S and anti-140S titres of the sera do not appear 
to fully explain the greater specificity of the two 140S antiser• 
compared with the live-virus antisera, since for HV 11/37, the 
two antisera were similar in thie respect but the value of L f~r 
the anti-140S serum wae lower than that for the live-virus anti-
serum ■ Nor do they explain the lower value for j obtained with 
'!'able 2-6 Cross-Cl-' test s us inr: live-virus and 140S antisera, 
with -pelleted 1 purified 140 5 and 12S anti1•iens 
Antigens Antisera I, ( RV1 1/37) I ;, (BUT1/6b) 
pelleted live -vi rus 0 . 30 0 .71 
pelleted 1-+0::i 0 .1 2 0 .25 
purifie d 1408 live-viru s 0.25 0 . 85 
purified 140S 14os 0 .06 0.25 
125 live-vi rus 0 . 3 0 0.35 
125 140S 0.30 0.25 
•rable 3.·; knti se rum titres a1,ains t homologous purif ied 
1405 and 12S anti 5ens 
Anti gen Antiserum Antise rum titre 
140S RV 11/3? live-virus 204 
12S ~v 11 /37 live-v irus 128 
140S HV 11/37 14 S 204 
12S RV 11/37 14 CS 181 
140S BOT 1/6 8 live-virus 115 
12S BVl' 1 /68 live -v irus 181 
1403 so·r 1/68 140 5 724 
12S BO'l' 1/6b 1405 
181 
1i 
4 6% 
18% 
47% 
1 2% 
3~/4 
3 0'/4 
the live-virus antisera, when tested aeainst 12S anti e ens, 
compared with pelleted or purified 140S anti gens ( Table 3 0 6) 0 
These anomalies were not resolved. dowever, it indicates that 
the results of cross-GF tests with antisera which have not been 
fully characterised, must be interpreted with considerable care. 
The implications of this are discussed further in Section 3.4 (b). 
3 .4 DISCUSSlvH 
3 . 4 (a) ComDeriaon of the CF Test with other lmmunological Methods 
for Strain Differentiation 
In this Section, an attempt has been made to provide some 
evidence that the differences between strains as detected by CF 
can be correlated to those differences which are d~tected on the 
basis of cross-neutralisation or cross-protection. It would 
appear reasonable to assume that if the differences determined 
by CF, by neutralisation in vitro and by protection in vivo are 
of a similar magnitude then in e~ch system the same combinations 
of antigen and antibody are being detected. 
For the two strains, A6003 and A6900, the relationships 
determined by CF (short-fixation in tubes; from ~ection 1.3 (b)), 
by conventional cross-neutralisation, by kinetic neutralisation 
and by animal cross-protection were expressed as values for i, 
!(CN), !(KN), and li(CP) respectively. These relationships are 
comparable in bein~ derived in the same manner from values ror 
£• which in each case were determined as the proportion of heter-
ologous reaction/homologoue reaction, for two antiBene reacting 
with one antiserum (or, in the case of cross-protection, two 
viruses challengine guinea pigs inoculated with one vaccine). 
The value• for ,!i, ji(Cl~), j(KN) and ji(CP) were respectively, 37,., , 
}~~ , 4&~ and }5"fo• Since they are all of a similar order, this 
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provides some support for the validity of using CF to determine 
the relationships between strains. It is reco gnised t hat further 
comparisons of a similar nature would be desirable but these 
must inevitably be limited by the high cost of large-scale 
animal experiments. 
It i s evident that the g uinea pi 6 protection test described 
in this Section is an effective method for the detection of 
strain differences. Animal protection tests suffer from the 
disadvantages of being costly and time-consuming and of being 
subject to considerable variation due to differences in individual 
animal susceptibility. Their g reatest advantag e is that differences 
determined by animal protection are closely analogous to the 
situation for which the information is require d; viz., the 
susceptibility of vaccinated animals to challenge in the field. 
The results obtained in the test described in Section }.3 (a), 
suggest that variation in individual animal susceptibility was 
not an important source of error, sinc e all end-points were 
clearly defined over a range of only one or two vaccine dilutions. 
The use of vaccines prepared from purified 140S anti gens for 
cross-protection teats has not been previously ~e ucribed. nor 
has the response of guinea pigs to challenge after vaccination 
with such preparations. Mowat (1972) de t ermined the PD50 for 
pigs and cattle of purified 140~ anti gen vaccines prepared from 
straiD• of types A, SAT 2 and Asia 1. For pi gs, the o5 values 
ranged from 5.8 ng. to 14.1 ng., dependi n g on the strain and for 
cattle, from 32 ng. to 255 ng. The pr•••nt r e aulte auggeat that 
guinea pigs require similar doses of 1*0S antigen to cattle, for 
protection a gainst homolo gous challeng e. 
Morgan~• (1970) vaccinated guinea pigs 1'fith purified 
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1403 anti gen and me a sured the deve lopment of ne utra lisin 0 an t i -
bod y in their s era. They foun d that only guinea pi gs inoculated 
with more than 160 ng. of anti gen, had detectable levels of 
neutraliaine antibod y 2~ da ys after vaccination. The present 
results confirm these findings. 
Neutralisine kine t ics have been used for strain differentiation 
within many virus groups; for example, picornaviruses ( Mc Bride, 
1959; Richter, 1972), influenza viruses (Pereira an d Tumova, 1967), 
reoviruses ( Munro an d Wooley, 1973) and poxviruses ( Dunlap and 
Barker, 1973). Capstick .!!...!1• (1 959) studied neutralisation 
kinetics with F~iDV but the method has not previously been applied 
to FM DV strain differentia ti on. r he rnetnod was s hown to be 
reasonably r eproducible and to demo i.strate differences between 
two strains to a similar extent to CF. From the results of the 
present work, it would appear that the kinetic neutralisation test 
has no advantage over the CF teat for sensitivity or reprod-
ucibility. However, it could prove to be a useful method for 
the detection of strain differenc e s where antiaera suitable for 
CF are not available. 
The co nventional cross serum neutralisation test performed 
in microplatea also appeared to provide a satisfactory differ-
entiation between the two strains. It is a eimple and rapid 
technique and for this reason could have a g reater application 
than the kinetic test as described in thi ■ Section . For both 
of these neutralisation tests, a more extensive evaluation is 
required, before their reproducibility and th■ ir u~e!ulnees for 
FMD V strain differentiation can be fully assessed. 
The reasonably close agreement between the results or the 
cross-protection teat, the CF test and the croas-neutral1sation 
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teats, support the conclusions of the other workers referred to 
earlier ( Section 3.1). However , as previously pointed out, most 
of the earlier work was not carr ied out on a quantitative busis. 
Guerche ll...!l• (1972) suggested tnat strains which were dist-
inguishable in cross-protectio n tests, could not be differentiated 
by CF. however, sinc e their two strains, A6003 and A6900, were 
used for the present work in whic h they were clearly differ-
entiated by both methods, their conclusion is refuted. 
3 . 4 (b) The Sub-tvne Classification of FMDV Strains 
From the results of cross-CF tests carried out with SAT 1 
strains, it is apparent that the anti genic variation between 
strains (as expressed in valueH for~) is greater than has 
previously been recognised. As discussed in Section 2.4, it is 
likel~ that the CF test used by previous workers for FXDV strain 
differentiation, tenJed to mask differences between strains by 
enabling antigens of low sub-type specificity to interfere with 
the results. Also, it has been shown in this Section t hat anti-
eera prepared usine live virus may be inferior for distinguishing 
anti e enic differences. On the other hand, it was found that 
pelleted antigens were as good as purified 140d antigens for 
determining strain differences. 
The results obtained from the Ci tests between ~AT 1 strains 
were not all strictly comparable, uue to the two types of antisera 
u3ed. However, a eufficient number of reaulta were obtai~•d 
uaing anti-140ti sera to su~geat that tley give a real indication 
of the degree of antigenic variation that can be encountered 
within a type. 
Brooksby (19b8) suggested a value of I ■ 1C~ as representing 
the greatest difference that occurs between strains of the same 
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type. The results in this Section demonstrate that differences 
can be much g reater than this ~down to as low as 2'1. ) . lt can 
also be seen tllat if Ji 70-,v was the smallest d i f ference se:i'a rating 
sub-types, then almost all of the strains examined would be 
classified as different sub-types. This would provide little 
information regarding the inter-relationships between the strai fi s. 
It is suggested that a more realistic level for sub-type differ-
entiation would be 1i .. 25,v, which represents a four-fold difference 
between the homologous and heterologoua titres of the antisera of 
the two strains being compared. It is only around this level of 
differentiation that differences detected in micropla te teats 
become meaningful, the detection of smaller differenc e s requiring 
more accurate techniques (such as the tube teat described in 
..;ection 1). 
~xamination of the relationships obtained for the S AT 1 
strains (Table 3.5), reveals that these strains cannot be placed 
into groups based on a level of differentiation of _!i = 25~• , such 
that all strai .1s within a group are more closely related to each 
other than to strains in other groups. It follows that these 
strains cannot be classified in this way, so as to fulfil the 
conditions of Brooksby's (1968) definition. Consequently a new 
approach to sub-type classification is suggested. 
Since all strains cannot be uniquely cl~saified, it is 
proposed to strictly classify only reference strains, one for 
each sub-type, such that the relationship of one reference strain 
to all ottler reference strain" is .!i (25',.. he aelection of 
reference strains with incomplete historical data must be some-
what arbitrary but has a chronological basis. Once selected, 
reference strains are fixed. All other strains are classified 
as related strains. in all sub-t yp e groups wit h wh os e reference 
strain the y have a r e lationship of _!! ) 2 551, . ~ rom the results 
o btained with the SAT 1 strains ( Table 3 . 5) a sub-t ype class-
ification can be made as s hown in Table 3.8 . 
The system ma y a ppear t o increase the co mplexit y of sub-
t ype classification. tiowever, if t he concept of sub-type - as 
presently acce pted ( Brooksby, 1968 ) is to b e retained at all, 
then it must be in such a form as to allow t h is flexibility in 
classifying related strains. The exhaustive characterisation of 
related strains is not essential as the divisio n into sub-types 
depends onl y on the identification of reference strains. The 
six strains presently classified in the ~orld deference Labor-
atory as separate sub-t;pes, are all contained in the first 
three sub-type g roups in Table 3.8. The identification of a 
further six groups demonstrates the antigenic diversity o f 3 1 
strains which have not been previously classified. 
Ta h1e ~.8 Sub-type classification of SAT 1 strains 
3ub-type 
SA'l' 1/1 
SAT 1/2 
...;;..T 1/3 
.:,.I\T 1/4 
SAT 1/5 
3~1' 1/6 
..iiL'11 1/7 
,'.;A'.r 1/8 
SA'.r 1/9 
Reference strain 
RV 11/37 
SA 13/61 
TUR 323/62 
GHA 14/68 
MAL 3/70 
HHCJ 4/72 
ANG 9/72 
GHA 7/73 
iAM 25/73 
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rtelated strains 
S dA 1/49, S R 2/58 
S dA 1/49, SR 2/58, SdA 40/61 
SH 2/58, SwA 40/b1, BO'r 1/68, 
UGA 47/71, K.i,;N 3/72 
BO'r 1/68 1 Ki::N 3/72 
NIG 9/72 
It is suggested that the proposed system is a more realistic 
approach than the present sub-t ype classification , since it is 
based on the observed characteristics of va riation between 
strains. The main implication is that an anti genic chang e tnat 
occurs to form a new sub-type, does so by a number of small 
alterations as a gradual process, rather than in a single step. 
This is reasonable, since the antige nic structure of the virus 
and the smallness of a change whic h can alter anti genicity, make 
the possibilities for continuous minor alterations almost 
unlimited. It is also supported by evidence of Hys lop (1 965) 
and Hyslop and Fa gg (1965 )• They passaged viruses serially in 
tissue culture under the selection pressure of antiserum homol-
ogous to the starting virus, and through partially immune cattle. 
Antigenic modification occurred, so that the passaged strains 
became progressively more different to the starting strains. 
l-'ringle ( 1969) found that phenotypic mixine between HiuV 
strains was an infrequent occurrence and argued that as a 
consequence, any mutation affecting the antigenicity of the 
virus would be immediately expressed. He suggested that this 
may in part explain the extensive antieenic variation of FMDV 
in comparison with, for example poliovirus, which exhibits 
extensive phenotypic mixing and is antigenically more stable. 
If this property does in fact allow for an immediate expression 
of, and selection for, minor antigenic changes, then it would 
further implicate antigenic drift as the mechanism for intra-
type anti genic variation. 
In accordance with the proposed n•~ classification, a sub-
type can be re-defined as follows: "An F' UV sub-t::rpe is an 
antigenic grouping o:t' closely related strains within a type. All 
strains within a sub-type are related to one particular reference 
strain, such that B_ ) 25%• Reference strains of each sub-type 
differ from each other to the extent that E < 25''-' • A strain can 
be classified into more than one sub-type group according to its 
relationship to the reference strains." 
The role of antiserum quality in the determination of strain 
differences has not been investi6ated in detail. nowever it is 
recognised that variations in specificity and avidity between 
different antisera are of considerable importance in this respect. 
It is apparent from the results in Sections 2 and 3 that if 
the 140s antigens of two strains are compared in cross-CF tests, 
then the values for£ for the two antisera are not nece s sarily 
equal. Since this inequality is still observed using 12S-adsorbed 
antisera (Section 2.3), then it cannot be fully explained on the 
basis of t be relative proportions of anti-1405 and anti-12S anti-
body in the sera. However it was shown in this Section (Table 
3.6), that the value for£ can differ between two antisera of 
the same strain prepared by different methods. Thia demonstrates 
the importance of antiserum quality and the necessity to main-
tain uniformity in the method of antiserum preparation to minimise 
this effect. lt also suggests the possibility of preparing anti-
sera of even greater specificity. The preliminary results of 
work currently in progress suggest that it is possible to prepare 
antisera of greater sub-type specificity, with which small anti-
genic differences are readily detected even in long-fixation 
t est• • 
stellmann ~• (1~'l2 a and b) introduced the concept of 
dominance into the classification of FMDV strainu. They suggested 
that the antiaera of "dominant" strains are more cross-reactive 
and propose d a mathemat ical system for t he dete rmination of 
dominance on the bas i s o f the ine qualit y i n value s fo r£• 
while t h e concept o f dominance is re asonable and pos s i bly 
i mportant (for example, in the selection of vaccine strains), 
it appears for the reas o~s discussed above, to be dancerous to 
attribute unequal values of£ between two strains, to the effect 
of dominanc e ■ ~tellmann ~• provided no information re ga rding 
the preparation or qualit y of their antisera and it is suggested 
that without a dequate characterisation of antisera, the question 
of dominance cannot be investigated in this way. 
~.5 CUNCLUS IUNS 
Strains which had been differentiated by Cf , were compared 
by a guinea pi g protection test, kinetic neutrali sation and cro s s-
neutralisation tests ■ lt was shown that these tests, which have 
not been previously applied by the methods described, are all 
capable of FMDV strain differentiation ■ Similar difference• 
were found by all methods, which suggests that compariso ns made 
by cross-CF, cross-neutralisation or cross-protection involve 
measurement of the same anti gen/antibody interactions. 
The comparison of a large number of strains in cross-Cr 
tests, showed that the ranB• of anti g enic variation within a 
t ype was greater than had previously been described. Relation-
ships determined between strains, revealed that the present 
method of sub-type classification is unsatisfactory ■ A new 
system was proposed for the sub-type classification of FMDV 
strains. 
SUMMARY 
Complement-fixation was one of the earliest techniques 
developed for quantitative serological studies and it has foun d 
extensive application for more than fift y years in the field of 
FMDV research. The aim of t his thesis is to re-examine some of 
the methode used and the results obtained by earlier workers and 
to further exploit the app lication of CF to the study of ieolated 
H IDV antigens. 
The methodological studies in Section 1 1 indicated that some 
earlier workers (Bradish and Brooksby, 1960; Bradish~•• 
1960 a ) using CF for FMDV serological studies made certain 
incorrect assumptions concerning the quantitative aspects of 
the fixation of complement by I-'MDV and its antibodies. It was 
found that in the system described, using anti gens which are 
relatively complex, the fixation of complement follows the 
principles determined by Mayer~- (1948) and Osler~• 
(1948) using well defined antigen/antibody systems. FMDV strains 
could be differentiated in UF tests based on these principles, 
on which the conventional chequerboard titration has been est-
ablished; i.e. by comparing the titres of antisera when tested 
with homologous and heterologous antigens at their optimum con-
centrations. 
However, much of the work of Bradish and his associates was 
confirmed. It was found (Section 2) that the intact virion has 
no heterotypic activity but cross-reacts between sub-types, while 
the 12S sub-units, both naturally occurring and prepared by acid-
degradation of the virion, have a greater cross-reactivity 
between sub-types and some heterotypic activity. The non-structural 
virus infection-associated antigen had virtually no type or sub-
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SUMMARY 
Complement-fixation was one of the earliest techniques 
developed for quantitative serological studies and it has found 
extensive application for more than fifty years in the field of 
FMDV research. The aim of this thesis is to re-examine some of 
the methods used and the results obtained by earlier workers and 
to further exploit the app lication of CF to the study of isolated 
FMDV antigens. 
The methodological studies in Section 1, indicated that some 
earlier workers (Bradish and Brooksby, 1960; Bradish~-• 
1960 a) using CF for FMDV serological studies made certain 
incorrect assumptions concerning the quantitative aspects of 
the fixation of complement by FMDV and its antibodies. It was 
found that in the system described, using antigens which are 
relatively complex, the fixation of complement follows the 
principles determined by Mayer~• (1948) and Usler 2.L.!.!• 
(1948) using well defined antigen/antibody systems. FMDV strains 
could be differentiated in CF tests based on these principles, 
on which the conventional chequerboard titration has been est-
ablished; i.e. by comparing the titres of antiaera when tested 
with homologous and heterologous antigens at their optimum con-
centrations. 
However, much of the work of Bradish and his associates was 
confirmed. It was found (Section 2) that the intact virion has 
no heterotypic activity but cross-reacts between sub-types, while 
the 12S sub-units, both naturally occurring and prepared by acid-
degradation of the virion, have a greater cross-reactivity 
between sub-types and some heterotypic activity. The non-structural 
virus infection-associated antigen had virtually no t~pe or aub-
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type specificity. S tudies with other isolated anti gens revealed 
that empty capeids were anti genically i dentical to complet e 
virions, in contradistinction to the findi n gs of workers with 
other picornaviruaes, whose empty capsids are antigenically 
different, or only partially related to the complete virions. 
Virus particles treated with trypsin had a reduced sub-type 
specificity indicating that the polypeptide, VP1, is associated 
with a highly specific anti genic site. 
The use of sub-type specificity studies to compare different 
viral anti gens is an approach which has not been previously 
ap plied in FMDV research. iiowever it would appear ti.at it is a 
sensitive method for examini ng the relationshi p between the 
various structural antiGene of the virion. 
From the methodoloe ical studies of Section 1 and the anti-
genic analyses of Section 2, it was possible to make a number of 
observations regarding the application of CF to the type and sub-
t yp e identification of FHDV strains. It was suggested that by 
using antieera of good quality (such as those prepared usin~ 
purified, inactivated antigens,) a long-fixation CF test could 
be used for greater sensitivity of anticen detection in typing 
tests, without the complication of enhanced heterotypic crosa-
reactions. The use of a short-fixation period was advantageous 
for sub-t ype differentiation, as it increased the specificity 
of the test. A chequerboard titration method, as well as being 
quantitatively valid, minimises the effect of cross-reactions 
due to degraded anti gen. The method used by earlier workers for 
sub-type differentiation ( Davie, 1 964; Darbyshire .!.L.!!•• 1972) 
was invalid in principle and, in usin& undiluted crude antigen 
harvests, predisposed to cross-reactions due to 12~ and VIA 
anti ~ens. 
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1n 5ection 3, the relevance of CF for f MDV strain differ• 
entiation was examined. Quantitati v e differences betw een two 
strains were similar when measured by CF, by cross-protection 
and by cros s -neutralisation tests. It was areued that this was 
an indication tha t t he reaction measured by CF involves the same 
anti g ens which determine immunolo 0 ical specificity in terms of 
cross-neutralisation and cross-protection. 
The results of a large number of cross-fixation tests between 
FM~V strains of one type, suggested that t he present criteria used 
for the sub-type classification of FMDV strains is unsatisfactory. 
In particular, the character of antigenic variation, which 
appears to be a g radual anti genic drift from one sub-type to 
another, precludes the classification of strains such that each 
strain falls into only one sub-type group. A new classification 
system is proposed which is consistent with the observed character 
of antigenic variation between strains. Lnly reference strains 
are uniquely classified, one for each sub-type, while other 
strains are classified as related strains in one or more sub-
type groups. 
'!'he importance of antiserum quality was demonstrated, in 
relation to the measurement of anti ~enic differences between 
strains. Antisera differently prepared against the same virus 
strain had different sub-type specificities. 'l'he si gnificance 
of this was discussed in relation to the determination of 
"dominant" strains. 
Largely as a result of the work described in this thesis, 
the method for sub-type differentiation of FMDV strains in the 
Worid Heference Laboratory has been altered. Comparative studies 
a r e in proeress to evaluate the modifications proposed for FMDV 
type differentiation. 
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APPhNDICES 
1. Complement-fixation Reagents 
Veronal-buffered saline (VBS), used as a diluent for all 
reagents, was prepared using complement-fixation buffer tablets 
(Oxoid Ltd., London) giving the following co nstitutions-
barbitone 0 .575 g./1. 
sodium chloride 8.5 g./1. 
magnesium chloride 0.168 g./1. 
calcium chloride 0.028 g./1. 
barbitone soluble 0.185 g./1. 
Gelatin was added to o.1~ w/v and the pH was approximately 
The source of complement was serum from fasted, male guinea 
pigs, which was pooled and twice adsorbed at o
0
c with~ of 
washed sheep erythrocytes as recommended by Kabat and Hayer (1961). 
Complement was stored in small volumes at -?o0 c. 
Sheep erlthrocytes ( wellcome Research Laboratories, Beckenham) 
stored in Alsever'• solution, were washed at least three times 
in three yolumes of VBS or until a clear supernatant was 
obtained (Kabat and Hayer, 1961). After the final wa•h, the 
cells were centrifuged for 10 minutes at 500 g and 1 ml. of 
packed cell• wa• re-suspended in 50 ml. of V~S. The concen-
tration of erythrocytes was e•timated by lysing 1.0 ml. of the 
•uspen•ion with 9.0 ml. of dietilled water and mea•uring the 
optical deneity (OO) of the lyeate in a Pye Unioam SP500 Serie■ II 
•pectrophotometer at 541 nm. The •uspeneion wae then ■tandardieed 
by appropriate dilution to give a lyeate with an OD of o.}OO • 
0.005. 
Rabbit anti-sheep haemolytic serum (Welloome) w~• diluted 
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1/10 and stored in small volumes at -20° c. ~ rythrocytes were 
sensitised by slowly adding an equal volume of haemolytic serum, 
diluted to contain two minimal haemolytic doses of haemolyain 
and incubating in a water-bath at 37°c for 30 minutes with 
occasional mixing . The sensitised erytbrocyte suspension was 
then stored at 4°c prior to use. 
2 . Preparation of Viruses and Viral Antigens 
2 (a) Preparation of infective virus 
FMuV strains were obtained from the world Heferonce 
Laboratory. ~ach virus was passaged on cell monolayers of baby 
hamster kidney (BrlK-21 1 clone 13; Macpherson and Stok ~r, 1962) 
in Ro ux flasks until the virus was capable of destroying the 
cell sheet within 24 hours after inoculation at a low multi-
p1icity of infection (0.001 to 0.01 pfu./ml.). A monolayer 
comprising about 108 cells was rocked at 37°c during virus growth 
and maintained with 20 ml ■ of Eagle's medium supplemented to 10Ji, 
with tryptose phosphate broth. ~hen the cell sheet was destroyed, 
the contents of t ne Roux flask were frozen and thawed and the 
gross cellular debris removed by low speed centrifugation. The 
fluid was made up to 50';t> glycerol and .5% normal bovine serum and 
stored in small volumes at -70°C as virus seed. 
Each strain used to infect guinea pi gs was serially 
passaged by inoculation into the plantar pads until the virus 
was capable of producing generalised disease within 48 hours. 
Pads containing infective virus were ground with a pestle and 
mortar and suspended in o.o4M phosphate buffer pH 7.6 as a ~ w/• 
auspension of pad tissue. This was c1arified by low apeed 
centrifugation, made up to 5~ glycerol and stored at -20° c. 
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2 (b) Pre~aration of 140S antigen 
Virus grown in BHK cell monolayers in Houx flasks was 
harvested as infected tissue culture fluid, which was held at 
0 4 C for 24 hours prior to low speed centrifugation to remove 
gross cellular debris. where an inactivated preparation was 
required, the harvest was made to 0.05'~ acetylethyleneimmine 
(AEI) and held at 26°c for 30 hours. The reaction was then 
stopped by the addition of 1()<J6 of 20% sodium thiosulphate and 
innocuity verified by two negative serial passages on BHK mono-
layers. The procedure for virus purification then followed that 
described by Brown and Cartwright (1963). 
To the clarified harvest was added an equal volume of 
saturated ammonium sulphate in o.o4H phosphate buffer, pH 7.6, 
a t 4°c. After 30 minutes at ~ 0 c the resulting precipitate was 
deposited by centrifugation at 2000 rpm. (2000g) for 30 minutes 
in an MSE Mistral centrifuge. It was then drained and suspended 
in 1/15 of the original volume of o.o4M phosphate buffer and 
clarified by centrifugation at 10,uOO rpm. (12,000g) in the 
8 x 50 angle rotor for 30 minutes in an MSE ultracentrifuge. 
The virus was then sedimented by centrifugation at 30,000 rpm. 
(108,000g ) for 60 minutes in the same rotor. 
The pelleted virus was resuspended in o.o4H phosphate 
buffer to a volume of 1/300 of the harvest, c larified by centri• 
fugation at 12,000g for 15 minutes and -de up to 1~ w/v sodium 
dodecyl sulphate (SDS). Suero•• density gradient• , 15 to 45', w/T 
in o.o4H phosphate buffer, were prepared uaing a two-chamber 
mixing apparatus and the virus preparation was layered onto the 
top. Gradients were centrifuged either in the 3 x 25 ml. swinging 
bucket rotor for 2 hours at 30,uoo rpm. (129,000s ) or in the 
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lillli 1, 
6 x 14 ml. titanium swinging bucket rotor for 90 minutes at 
40,0UO rpm. (193,000t ) in the MS~ ultracentrifuge. 
After centrifugation, fractions fro m a g radient were 
collected by positive pressure displacement through a hole 
pierced in the base of the centrifuge tube. Fractions containing 
tue virus peak were identified by CF assay, pooled, diluted 1/4 
in VBS and stored at 4°c. 
2 Cc) Preuaration of emutv capsids 
The procedure for isolating empty (HNA-free ) capsids was 
similar to that for the purification of 140S antigen. However, 
in place of ~VS the resuspended pellet prepara~ion was instead 
made to 1~ w/v of Nonidet P40 (BVH Chemicals Ltd. ~oole, Dorset) 
prior to sucrose density gradient centrifugation in the MSE 
bx 14 ml. swingin~-bucket rotor. The peak fraction of 75S 
antigen, detected by CF assay and identified by its position in 
the gradient, was diluted 1/4 in VBS and stored at 4°c prior to 
use. 
2 (d) Prenaration of trypsin-treated virus 
Samples containing virus in resuspended pellet material were 
divided in two. Both parts were incubated at 37°C tor }O minutes, 
one with 1 mg./ml. of crystallised trypsin (Armour Pharmaceutical 
Co. Ltd., ~aatbourne.) Samples from each were taken for intect-
ivity assay and tbe rest treated with SU~ and puritied by 
sucrose density gradient centrifugation in the MS~ 0 x 14 ml. 
swinging-bucket rotor. 
4{f ) f £enaration of artificial 12S antigen 
Peak fractions of 140S antigen from aucrose density gradients 
were pooled and degraded by the addition of two volumes of O.O5M 
NaB 2PU~, producing a final pK of approximately 6.2. lhe antigen 
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was then layered onto 15 to 25"/4 sucrose density g radients and 
centrifuged for 16 hours in the MS£ 6 x 14 ml. titanium swinging -
bucket rotor at 40,000 rpm. Peak fractions of 12S anti g en were 
identified by CF assay, pooled, diluted 1/4 in VBS and stored 
in small volumes at -70°c. 
2 {f) Preparation of natural 12S and VIA antigens 
Natural 12S and VIA antigens were prepared from the super-
natant remaining after pelleting the 14C~ antigen. The material 
was re-centrifuged at }0 1 00u rpm. for 60 minutes in the M~~ 
8 x 50 angle rotor to further reduce contamination with 140S 
antigen. It was then concentrated by ammonium sulphate precip-
itation, resuspended in a small volume of 0.01 M phosphate buffer 
containi ng 0.15M NaCl at pH 7.6 (0.01M PBS) and dialysed over-
ni Y,ht against tnia buffer. Material concentrated from the harvest 
of 20 Roux flask monolayers was then passed through a 15 x 1.5 cm. 
D~E cellulose (D~ 2 2, Whatman Biochemicals Ltd. Maidstone, Kent) 
column equilibrated with 0.01M PBS . After collecting 20 2.5 ml. 
fractions by washing with the equilibrating buffer, the column 
was then eluted with 320 ml ■ of a linear gradient of NaCl in 
0.01M PBti to 1M NaCl, using a two-chamber mixin1, a pparatus, and 
10 ml. fractions collected. Two peaks of complement-fixing 
activity were identified, one in the sample efflu~nt fractions 
and one in the NaCl eluate. These were concentrated by ammonium 
sulphate precipitation and dialysed against 0.04M phosphate 
bu!!er. Th•~ were then layered onto 15 to 25"/4 sucrose density 
gradients and centrifuged tor 16 houre in the M3E 6 x 14 ml. 
titanium swinging-bucket rotor at 40,000 rp111. Peake of 
complement-fixing activity were identified ae 12S and VIA 
antigen■ by their relative positions in the ~radient ■ (VIA 
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antigen sediments at approximately 4s ), diluted 1/4 in VBS and 
stored in small volumes at -7o0 c. 
2 CR) Radioisoto~e labellinR of antigens 
Radioisotopes were o btained from the nadiochemical Centre, 
Amersham, Bucks. 
Tritiated uridine was used for labelling of RNA. It was 
incorporated by introducing 100 ~Ci of 3H uridine into one Roux 
flask at the time of virus inoculation. 
Viral protein was labelled with 14c or 35s. In both 
instances the virus was Grown over a single growth cycle using 
a multiplicity of infection of 1.0 to 10. 10 pCi of 14c-
1abelled aleal hydrolysate or 200pCi of 3~s-methionine was 
added to one Roux flask 90 minutes after virus inoculation. 
Earle's saline or methionine-free Eagle's medium were used for 
maintenance of the monolayer for 14c and 35 incorporation 
respectively. 
The radioactivity of antigen preparations was determined 
by drying 50pl. aampl•• onto discs of Whatman P80 chromatography 
paper. These were placed into vials containing 2 ml. of 
scintillant, consisting of 0.1g. POPOP and 4g. PPO per litre ot 
toluene and counting th• samples in a Nuclear Chicago Unilux 
Scintillation Counter. 
3: Preoaration of Antiaera 
} (a) fr1PfraU9n o( antherum to live virus 
Guinea pig antiaera to live Yirua were produced by a method 
similar to that of Brookaby (1952). Guinea pigs wei1hing 
approximately 6uo g. were inoculated intradermally in the 
plantar root-pade with infective guinea pig adapted virue 
(Appendix 2 (a)). After three montha 1 they were ~iven a 
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succession of three hyper-immunising inoculations by the same 
route on three successive days, then killed and exsanguinated 
ten days later. The pooled serum was filtered and stored in 
small volumes at -20°c. 
~ (b) Pre~aration o f 140S-specific antiserum 
Antisera specific for 140S antigen were prepared in a 
manner similar to that of Brown and Smale (1970). Live virus 
antiserum was dialysed overnight against 0.011-1 phos,1mate buffer, 
pH 7 ■ 6 ■ Purified 14 $ anti gen was de graded by reduction of the 
pH to 5.2 by addine 1 0"/4 v/v of 1M acetic acid and concentrated 
by vacuum dialysis, a gai nst o.01M phosphate buffer. The dial.ysed 
reagents were titrated by CF in tubes to determine the dilutions 
of anti gen and antiserum which were optimally reactive. They 
were then mixed in a proportion which ensured an antigen excess ■ 
The mixture wa s held at 4°c for 18 hours and then passed through 
a Dl>AE-cellulose column, 1.5 cm . x 10 cm., equilibrated and 
eluted with 0.01M phosphate buffer. Under these conditions, IgM, 
antigen/antibody complexes and residual excess anti gen are 
retained in the column, while uncomplexed IgG pas••• through . 
After passage of the fluid volume of the column, a sin~le peak 
of hi gh ~D was detected. This was collected, inactivated by 
heating at 56°c for 30 minutes and teated by CF againet 1408 
and natural 12S antigens for specific antibody actiYity . Un 
verification of anti-1400 activity witb no oetectable anti-12S 
activity, the antiserum was diluted 1/4 in VBS and stored in 
small volume• at -20°c. 
It ehould be noted that no attempt was made to remove 
anti-VlA activity fro ,,, theee antisera1 i.e. they were 14os-
~r•clfic only in their reactivity twoards viral capaid componente. 
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~ (c) Pre~aration of anti-1403 serum 
Anti-1403 guinea pi g sera were prepared followin g the met hod 
of Cowan (1 968) . Pu rified, A~l -inactiva t ed 140S antigen 
(Appendix 2 (b ) ) from the harvest of 20 ~oux flask monolayers, 
was emulsified with incomplete f reund's adjuvant ( Uifco 
Laboratories, uetroit, P. ichigan, U. ~ .A.) and then re-emulsified 
with an equal volume of Tween 80 detere ent (Koch-Light 
Laboratories Ltd., Colnbrcok, Bucke.) forming a double emulsion. 
Five guinea pi gs were inoculated intramuscularly in the hind-
le g and hyper-immunised four weeks later with a similar amount 
of freshly-prepar e d 140.'.:i antigen, without adjuvant. •rhey were 
exeanguinated 10 days later and the pooled serum filtered and 
stored at -20°c. 
! (nJ P~Aoaration of anti-12S serum 
Artificial 12S anti gen was prepared from purified, A~I-
inactivated 140S antigen (Appendix 2 (e)). It was emulsified 
with incomplete Freund's adjuvant and then re-emulairied with 
an equal volume of Tween 80 detergent. Guinea pigs were inoculated 
intramuscularly. They were hyper•immunised 36 and 64 days later 
with similar antigen preparations, without adjuvant, by the same 
route and exsanguinated arter a further 12 days. 
I+ . Methnrl for RoutiJH Comple■ept-!iption Aeslll!,! 
Routine assays for the detection and measurement of the 
complement-fixing activity of viral antigens were performed in 
microplatea. ~•tails of the reagents used are &iven in Appendix 1. 
Samples were diluted in two-fold aeries in the plates, using 
diluting loops. To 25 pl. of anti~en were ad~ed 25 pl. of a 
fixed doe• of complement (5C 1 H50 ) and 25 pl. of antieer1&11, at 
leaet !our times the concentration of the antiserum titre. 
Suitable controls were included as appropriate, with complement 
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doses of 5, 2.5 and 1.25 c• tt 50 • Plates were incubated at 37°c 
for one hour (for detection of 1l►OS , 755 and T-140S antig ens) or 
at 4°c for 18 hours (for detection of 12S and VI A ant igens), 
after which 50.),11• of sensitised erythrocyte suspension was 
added and the plates incubated for 45 mi nutes at 37°c. They 
were then centrifuged for 10 minutes at 600 g. to deposit 
unlysed cells. 
~nd-points were determined as the hi ~he6t dilution of 
antigen which fixed 4 of 5 C1 H50 ; i.e. where 5~~ of the erythro-
cytes remained unlysed. ~here appropriate, interpolation between 
two dilutions was made by calculating the geometric mean. 
Results were recorded as the reciprocal of the antigen dilution 
at the end-point. 
5. Ht\hod fo; P~lvQcrvlamide 091 Electrophoresis 
The conditions for virus dissociation and electrophoresis 
of the polypeptides followed those described by Pereira and 
Skehel (1971). Purified intact or tryps i n-treated virus, 
labelled with 35s -methionine, in o.o4M phosphate buffer, pH 7.2, 
was mixed with urea, S OS and 2-mercaptoethanol to final concen-
trations of 5M, 1~ and~. respectively. The mixtures were then 
heated at 100°c for one minute and, after cooling, a 200.)ll• 
sample was applied to each gel. Gels of 5 ml. volume were 
prepared in perspex tubes of b.5 mm. internal diameter. They 
contained 7-~~ acrylamide, 0.2-~ bi 6cacrylamide, 5M urea, 0,05M 
sodium phosphate buffer 1 pH 7.2, 0.01M ~UTA , 0 .1~ SD5 and 0.1% 
T~MEU . Polymerisation was catalysed with 0.1% ammonium per-
■ulphate. The electrophoresis buffer was 0.05M sodium phosphate, 
pH 7.2, with 0.1% SDS and 0.01M ~UTA. Electrophoresis was 
ca~ried out !01 approximately 17 hours at a conatant potential 
of }O volts. 
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After electrophore~is, t he gels were proc e ssed for 
autoradiography following the method o f Hussell and S kehel (1 972 ). 
The g~ls were sliced long itudinally in an a pparatus similar to 
that of Fairbanks ~.(1965). The slices were washed twice 
in 71s acetic acid, laid on a porous plate, covered with cellophane 
and dried under vacuum overni ~ht. The dried gel stripe, attached 
to the cellophane were then used tor autoradiobraphy using Kodak 
X-ray film. 
6 - Estimation of ViruR lnfectivity by Plaque Assay 
Virus infectivity estimations were carried out by plaque 
assay using monolayer cultures of IH-HS-2 cells (de Castro, 1964) 
in 6 cml. Petri plates. The monolayers were g rown using a medium 
of 4~. t agles, 4 5,o lactalbumin yeast hydrolyeate (LYH), 10% 
bovine serum and antibiotics (100 units/ml. each of benzyl-
penicillin, neomycin and nystatin). The plates were incubated 
in an atmosphere of 5"~ co2 • The monolayers were confluent after 
4b hours and used at that time. 
After removal of the growth medium, monolayers were washed 
onc e with 5 ml. or phosphate buffered saline (PBS ) at room 
temperature and then inoculated with 200 JJl• or the virus 
samples. A period of 30 minutes at }7°C wae allowed for 
adsorption of virus, after which eacn monolayer waa covered with 
5 ml. or overlay, consisting of 4~~ LYH, 5~o urle's saline , 
Zi, bovine serum and 0.9'}(, • ~ar (Agaroae, L'lndustrie Biologique 
1''1•,ncaiae, S .A•, France)• 
The plate• wer e incubated for }O hours and the monolayers 
then fixed and stained with 3 ml. of formaldehyde and 10',(, 
saturated methylene blue in tap water. After allowing to stand 
overnight, the oyerlay wa■ remoYed and the p1aquea counted. 
126 
' - - : , - - I, - - --- ' - I l"' • I ., I~ - • 1 , - . •, . . - .. , - -· ...... , . .. . .. ' -··1',. 
For routine infectivity assays, samples were tested by 
inoculating two plates with each dilution in 10-fold series. 
The end-point was determined from the mean plaque count of a 
dilution producing between 10 and 100 plaques on each plate 
and expressed as plaque-forming units (pfu.) per ml. of undiluted 
sample. 
The plaque assay used for kinetic meutralisation tests is 
described in Section 3.2 (b). 
Z• Method for ~lectroohoretic Mobility Determinations 
Electrophoretic mobility determinations were made by 
sucrose density g radient electrophoresis using a p paratus 
described by Pringle (1969) and modified by Priston (1972). 
Cylindrical glass tubes, 60 cm. long and of 1 cm. internal 
diameter were supported vertically in a water jacket kept at a 
constant temperature of 10°c. Electrode baths were placed at 
the top (cathode) and bottom (anode) of the tubes. 
Linear sucrose density gradients• 5-4Cf/4 w/v in 0.01M tris + 
HCl buffer. pH 8.8. were formed in the tubes, using a two-chamber 
mixing apparatus. Bovine albumin powder was incorporated into 
the gradients to 0.1~ w/v. 
Samples of 1405 and T-140S antigens, with phenol red as a 
marker, were layered onto two columns and electrophoresis carried 
out for 16 hours at a constant potential of 240 volts and a current 
of 0.7 to 1. 2 ma. per column. ~ractions of 1.5 ml. were then 
collected from the bottom of the column. they were precipitated 
by adding an equal volume of 20)~ trichloracetic acid at 4°c and 
the precipitate collected onto discs of whatman P80 chromatography 
paper by suction. These were dried, and their radioactivity 
determined ae deecribed in Appendix 2 (g). 
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8. The Serum Neutralisation Teet 
Se rum neutralisation tests were c a rried out in disposable 
tissue-culture grade microplates (Linbro/Biocult) usin6 I B-RS-2 
cells (de Castro, 1964). 
The medium used for the dilution of all reagents was 85% 
Eagles, 10~ tryptose phosphate broth, 4~ normal bovine serum and 
1% w/v of U-glucose ■ ~era were inactivated at 56°c for 30 
minutes and diluted in two-fold steps, either in the plates with 
diluting loops, or in bottles and added to the wells in 50pl ■ 
volumes with dropping pipettes. A 50pl ■ drop of virus was added 
to each well and the plates were incubated for 60 minutes at 37° c 
in an atmosphere of 5¼ Cu 2 • Viruses were titrated in the same 
test, using log10 1.0 intervals with eight replicates. Reference 
eera were also included where appropriate, a gain using eight 
replicates. After incubation cells were added in a 50)11• drop 
6 
at a concentration of 1.5 x 10 /ml ■ The plates were then sealed 
with adhesive tape and incubated at 37°c for 48 hours. 
Tests were read by examining the monolayers microscopically 
or by fixing with formalin and staining with methylene blue. 
The virus was considered neutralised if more than half of the 
monolayer in a well ~as intact. Antibody titres were determined 
by the method of Karber (1931) and eicpreesed as the reciprocal 
or the highest dilution of serum which resulted in neutralisation 
of the virus. 
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